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PREFACE 
The risks, morbidity and in some cases, subsequent mortality associated with pregnancy 
(especially in certain parts of the world) are unacceptable for a basic life event that should 
come with great expectations and boundless excitement. I have therefore decided to focus my 
dissertation on this topic and join others before me on a journey that has the potential to 
impact countless number of lives due to the preventable nature of a number of these deaths. It 
is my hope that my research on this topic (as well as the tireless efforts of other researchers 
and health care workers in this field), will help us understand and find solutions to the major 
drivers of adverse pregnancy outcomes such as maternal mortality and preterm birth, and 











 ix  
 




List of Tables………………………………………………………………………………………………………………………...xi  
List of Figures……………………………………….……………………………………………………………………………..xiii 
List of Abbreviations  ……………………………………………………..……..……………………...…………………  xvi 
List of Appendices………………………………    ………………………………………………………………………….xviii 
Abstract....…………………………………………………….…………………………………………………………….………xx 
Chapter 1: Dissertation Introduction 
    1.1  Introduction................................................................................................................... ......1 
    1.2  Background and Public Health Significance.................................................................... .....1 
    1.3  Risk Factors..................................................................................................................       ..3 
    1.4  Inflammation and Preterm Birth................................................................................      .... 4 
    1.5  Cytokines During Pregnancy                   5 
    1.6  Research Setting and Data                      6 
    1.7  Summary and Specific Aims                               6     
    1.8  References                     9 
Chapter 2: Inflammation During Pregnancy:  Characterization of Cervico-Vaginal Cytokines  
in Term Births Using Longitudinal Data 
     2.1 Abstract                               12 
     2.2  Introduction                               14 
     2.3 Methods                               15 
     2.4 Results                                22       
     2.5 Discussion                                     25     
     2.6 References                  44  
Chapter 3: Concurrent Repeated Measures of Systemic and Reproductive Tract Cytokines 
During Term Pregnancy: Implications for Evaluating Environmental Contributors to 
Inflammation
 x  
 
     3.1 Abstract                              47 
     3.2  Introduction                  49 
     3.3 Methods                                50  
     3.4 Results                   54  
     3.5 Discussion                  56  
     3.6 References                     68 
 
Chapter 4: Cervico-Vaginal Cytokine Concentrations During Pregnancy and the Risk of 
Preterm Birth: A Comparative Analysis 
     4.1 Abstract                  71  
     4.2  Introduction                                         73 
     4.3 Methods                  75 
     4.4 Results                   79  
     4.5 Discussion                  80  
     4.6 References                104 
  
Chapter 5: Dissertation Conclusion 
     5.1 Research Overview and Implications             106 
     5.2 Strengths and Limitations              107  
     5.3 Future Directions               108  
     5.4 References                111 
 








LIST OF TABLES 
Table 2.1: Demographic and obstetric characteristics of Mexican women delivering term  
births, 2009-2014 (N=181).                 32  
Table 2.2: Percent of cervico-vaginal cytokine concentrations below the lower limit of  
detection (LOD) and above the upper LOD based on the manufacturer's manual, among  
181 pregnant women in Mexico City, over entire pregnancy and range by month.               33  
 
Table 2.3: Distribution of cervico-vaginal cytokine concentrations (in pg/mL) in Term 
 Births by Trimester (Number of samples = 902).              34  
Table 2.4: Intraclass correlation coefficients of cervico-vaginal cytokine concentrations  
in term births (N=181), Mexican Cohort, 2009-2014.             35  
Table 3.1: Demographic and obstetric characteristics of pregnant women delivering at  
term (N=104), Mexico City, 2009-2014.               61  
Table 3.2: Lower limits of detection (LOD) and descriptive statistics for concurrently  
measured cervico-vaginal exudate (CVE) and serum cytokine concentrations (in pg/mL),  
during overall pregnancy and specific months in gestation, among 104 pregnant women 
 in Mexico City, 2009-2014.                62  
Table 3.3a: Intraclass correlation coefficients of serum cytokine concentrations in term  
births.                   63  
Table 3:3b: Intraclass correlation coefficients of cervico-vaginal cytokine concentrations 
 in term births.                 63  
Table 3:4: Standard deviation (s.d.) changes in seven log-transformed pro-inflammatory 
cytokines from cervico-vaginal exudate (CVE) and serum and corresponding standard  
errors (s.e.) per 10 unit higher ambient air pollutant concentration near residence, 1 day 
 prior to clinic visit. Results are from infection and age-adjusted Tobit regression models  
that account for censored cytokine concentrations and repeated measures within 104  
pregnant women residing in Mexico City, Mexico, 2009-2014.          67   
 
Table 4.1: Demographic and obstetric characteristics of Mexican women who delivered term 
(N=78) and preterm babies (N=12), Mexico City, 2009-2014.           85 
 
Table 4.2a: Categories based on pro-inflammatory and anti-inflammatory ratio scores 
 xii  
 
 by outcome among 90 pregnant women in Mexico City, 2009-2014.                    102  
 
Table 4:2b: Categories based on pro-inflammatory and anti-inflammatory ratio scores  
by outcome among pregnant women in Mexico City, 2009-2014 using data with varying 
 degrees of follow up across trimesters.            102 
  
Table 4.3: Adjusted odds ratios (OR) (95% confidence intervals) for preterm birth per 
 log unit increase in cervico-vaginal cytokine concentration (pg/mL) from models† 
 including one trimester alone (individual), and overall average (average), from a  

























LIST OF FIGURES 
Figure 1.1: Estimated preterm birth rates by country for the year 2010.12               8 
 
Figure 2.1: Correlation heat map based on Spearman correlation coefficients for  
cervico-vaginal cytokines at month 3 of gestation.           36  
 
Figure 2.2: Correlation heat map based on Spearman correlation coefficients for  
cervico-vaginal cytokines at month 5 of gestation.           37 
  
Figure 2.3: Correlation heat map based on Spearman correlation coefficients for  
cervico-vaginal cytokines at month 7 of gestation.           38 
 
Figure 2.4: Longitudinal Cytokine Patterns for IL-1RA, IL-4, IL-10, and IL-12p40  
from Tobit regression models adjusted for infection.          39  
 
Figure 2.5: Longitudinal cytokine patterns for IL-1α, TNFα, IL-12p70, and sIL2rα  
from Tobit regression models adjusted for infection.          40 
 
Figure 2.6: Longitudinal cytokine patterns for Eotaxin, IP-10, VEGF, and IL-17  
from Tobit regression models adjusted for infection.          41 
 
Figure 2.7: Longitudinal cytokine patterns for MIP-1α, MIP-1β, MCP-1 and IL-6  
from Tobit regression models adjusted for infection.         42  
 
Figure 2.8: Longitudinal cytokine patterns for IL-8, IL-2, IL-1β, and IFNγ from Tobit  
regression models adjusted for infection.           43 
 
Figure 3.1: Correlation map based on Spearman coefficients for cervico-vaginal  
and serum cytokines for women who delivered at term using data from gestation  
month 3.               64 
 
Figure 3.2: Correlation map based on Spearman coefficients for cervico-vaginal  
and serum cytokines for women who delivered at term using data from gestation  
month 5.               65 
 
Figure 3.3: Correlation map based on Spearman coefficients for cervico-vaginal  
and serum cytokines for women who delivered at term using data from gestation 
 month 7.              66 
 
 xiv  
 
Figure 4.1: Cumulative distribution functions of cytokines (IL-1RA and IL-1α)  
evaluated among term and preterm births at three time points during pregnancy  
among 90 Mexico City-based pregnant women, 2009-2014.        86 
 
Figure 4.2: Cumulative distribution functions of cytokines (IL-1β and IL-10)  
evaluated among term and preterm births at three time points during pregnancy 
 among 90 Mexico City-based pregnant women, 2009-2014.        87  
 
Figure 4.3: Cumulative distribution functions of cytokines (IL-2 and IL-4) evaluated  
among term and preterm births at three time points during pregnancy among 90 
 Mexico City-based pregnant women, 2009-2014.          88 
 
Figure 4.4: Cumulative distribution functions of cytokines (IL-6 and IL-8) evaluated 
 among term and preterm births at three time points during pregnancy among 90  
Mexico City-based pregnant women, 2009-2014.          89 
 
Figure 4.5: Cumulative distribution functions of cytokines (IL-12p40 and IL-12p70)  
evaluated among term and preterm births at three time points during pregnancy 
 among 90 Mexico City-based pregnant women, 2009-2014.         90 
 
Figure 4.6: Cumulative distribution functions of cytokines (IL-17 and Eotaxin) evaluated  
among term and preterm births at three time points during pregnancy among 90  
Mexico City-based pregnant women, 2009-2014.          91 
 
Figure 4.7: Cumulative distribution functions of cytokines (MIP-1α and MIP-1β)  
evaluated among term and preterm births at three time points during pregnancy 
 among 90 Mexico City-based pregnant women, 2009-2014.       92 
 
Figure 4.8: Cumulative distribution functions of cytokines (TNFα and VEGF) evaluated 
 among term and preterm births at three time points during pregnancy among 90 
 Mexico City-based pregnant women, 2009-2014.         93 
 
Figure 4.9: Cumulative distribution functions of cytokines (MCP-1 and IFNγ) evaluated  
among term and preterm births at three time points during pregnancy among 90  
Mexico City-based pregnant women, 2009-2014.         94  
 
Figure 4.10: Cumulative distribution functions of cytokines (sIL2Rα and IP-10) evaluated  
among term and preterm births at three time points during pregnancy among 90  
Mexico City-based pregnant women, 2009-2014.         95 
 
Figure 4.11: Correlation map based on Spearman coefficients among cervico-vaginal  
cytokines for women who delivered at term using data from gestation month 3.     96 
 
 xv  
 
Figure 4.12: Correlation map based on Spearman coefficients among cervico-vaginal  
cytokines for women who delivered at term using data from gestation month 5.     97  
 
Figure 4.13: Correlation map based on Spearman coefficients among cervico-vaginal  
cytokines for women who delivered at term using data from gestation month 7.     98 
 
Figure 4.14: Correlation map based on Spearman coefficients among cervico-vaginal  
cytokines for women who delivered preterm using data from gestation month 3.     99 
 
Figure 4.15: Correlation map based on Spearman coefficients among cervico-vaginal  
cytokines for women who delivered preterm using data from gestation month 5.    100  
 
Figure 4.16: Correlation map based on Spearman coefficients among cervico-vaginal  

















 xvi  
 
LIST OF ABBREVIATIONS 
BMI Body Mass Index 
CI Confidence Interval 
CO  Carbon monoxide 
ECDF Empirical Cumulative Distribution Function 
ICC Intraclass correlation coefficient 
IFNγ Interferon gamma  
IL-10 Interleukin – 10 
IL-12P40 Interleukin-12p40 
IL-12P70 Interleukin-12p70 
IL-17 Interleukin -17 
IL-1RA Interleukin-1 receptor antagonist 
IL-1α Interleukin - 1 alpha 
IL-1β Interleukin - 1 beta 
IL-2 Interleukin – 2 
IL-4 Interleukin -4 
IL-6 Interleukin-6 
IL-8 Interleukin-8 
IP-10 Interferon gamma inducible protein -10 
LMP Last menstrual period 
LOD Limit of Detection 
MCP-1 Monocyte chemoattractant protein-1  
MIP-1α Macrophage inflammatory protein 1 alpha  
MIP-1β Macrophage inflammatory protein-1 beta  
NADA Nondetects And Data Analysis 
NLMixed Non-linear mixed models 
OR  Odds ratio 
PM10 Particulate matter less than 10 μm in aerodynamic diameter 
PPM Parts per million 
PPROM Preterm premature rupture of membranes 
PROM Premature rupture of membranes 
sIL-2Rα Soluble IL-2 receptor alpha  
SIMAT Sistema de Monitoreo Atmosférico 
TNFα Tumor necrosis factor - alpha  
UNAM National Autonomous University of Mexico  
VEGF Vascular endothelial growth factor  
 xvii  
 























 xviii  
 
LIST OF APPENDICES 
A. Table S2.1 Cytokine, the minimum detectable concentration in pg/ml, intra-assay         
coefficient of variation (CV) %, and inter-assay CV % respectively for each  
cytokine.               112      
 
B. Table S2.2. Spearman correlation coefficients, corresponding number of  
observations, and p-values adjusted for false discovery rate* for pairs of  
cervico-vaginal cytokines for months 3, 5 and 7 of gestation for term births in  
Mexico City.                113  
 
C. Figures S2.1. Cumulative distribution functions of cytokines (IL-1α, IL-1β, IL-1RA, 
 and IL-2) evaluated among term births at three time points during pregnancy  
among 181 Mexico City-based pregnant women, 2009-2014.         118  
 
D. Figures S2.2. Cumulative distribution functions of cytokines (IL-4, IL-6, IL-8,  
and IL-10) evaluated among term births at three time points during pregnancy  
among 181 Mexico City-based pregnant women, 2009-2014.         119  
 
E. Figures S2.3. Cumulative distribution functions of cytokines (IL-12p40, IL-12p70,  
IL-17, and INF-γ) evaluated among term births at three time points during  
pregnancy among 181 Mexico City-based pregnant women, 2009-2014.                    120  
 
F. Figures S2.4. Cumulative distribution functions of cytokines (IP-10, Eotaxin,  
MIP-1α, and MIP-1β) evaluated among term births at three time points during 
pregnancy among 181 Mexico City-based pregnant women, 2009-2014.       121 
 
G. Figures S2.5. Cumulative distribution functions of cytokines (MCP-1, sIL-2Rα,  
TNFα, and VEGF) evaluated among term births at three time points during  
pregnancy among 181 Mexico City-based pregnant women, 2009-2014.       122 
 
H. Table S4.1.  Table 4.3. Adjusted* odds ratios (OR) and 95% confidence intervals  
for preterm birth per log unit increase in cervico-vaginal cytokine concentration  
(pg/mL) from models† including one trimester alone (individual), all three  
trimesters entered (combined), and overall average (average), from a cohort in  
 xix  
 

















 xx  
 
ABSTRACT 
Preterm birth (PTB) is a global public health problem with significant short and long 
term effects. Preterm babies are at increased risk of neonatal mortality and long term 
morbidity.   While the etiology of PTB is poorly understood, inflammation occurs frequently in 
the pathway between several identified risk factors and PTB.  Inflammation is also a normal 
part of pregnancy.  Therefore, longitudinal measures are required to evaluate when and what 
markers of inflammation are normal and what predict PTB.  The objectives of this dissertation 
were to evaluate the expression of inflammatory biomarkers (specifically cytokines) during 
pregnancy, and to explore whether patterns of cytokine secretion can identify women at risk of 
PTB.  
Using longitudinal data from a pregnancy cohort in Mexico City, this dissertation 1) 
characterized 20 cervico-vaginal cytokines obtained during gestation and described cytokine 
patterns among 181 term births; 2) evaluated differences in concurrently measured systemic 
and reproductive tract cytokines, and evaluated the associations between air pollution 
exposure and serum and cervico-vaginal cytokines among 104 term births; and 3) compared 
cytokine expression between women who delivered term (n=78) and preterm (n=12); and 
evaluated associations between individual and patterns of cervico-vaginal cytokines at points in 
pregnancy and PTB.    
Among term births, mean cervico-vaginal cytokine concentrations were stable during 
gestation within cytokines but varied across cytokines; inflammation severity varied.  Cervico-
 xxi  
 
vaginal cytokines were uncorrelated with serum cytokines; air pollution was positively 
associated with serum but inversely associated with cervico-vaginal cytokines. Finally, cervico-
vaginal cytokine concentrations differed between term and PTBs, and the first trimester was 
most predictive of PTB. 
This dissertation increases understanding of the role of inflammation and PTB. The 
range of cytokines in normal pregnancy is wide, such that deviation from ‘mean’ concentrations 
is an insufficient marker of risk; the effects of air pollution on these levels may be specific to 
serum or the cervico-vaginal cavity. Finally, early differences in cytokine levels between term 
and preterm births may be useful for risk identification. Future studies should use other 
cytokine categories, particularly ratios and inflammatory milieu, to assess for deviations from 



















In 2000, the General Assembly of the United Nations adopted the United Nations 
Millennium Declaration, in which the global community was called to work together to “uphold 
the principles of human dignity, equality and equity”. To achieve its objectives, the Millennium 
Declaration was further defined to highlight eight specific goals along with  associated targets 
(commonly known as the Millennium Development Goals).[1]  Among the eight goals identified, 
two – “Improve maternal health” and “Reduce child mortality” – are especially affected by 
preterm birth, which is the focus of this dissertation.  
1.2 Background and Public Health Significance 
Preterm birth is an outcome of pregnancy in which delivery of a live infant or infants occurs 
before 259 days or 37 completed weeks of gestation.[2]  Preterm birth is a public health 
problem of global significance with far reaching implications.  It is a major cause of morbidity 
and mortality among infants, and preterm babies that survive often experience lifelong medical 
complications which can be taxing on families and health care systems.[3] In some rural or 
resource limited settings where health facilities are not only few and far away but also under-
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equipped to handle complications, preterm birth may play a role in maternal morbidity and or 
mortality.[4] Furthermore, the burden of preterm birth extends to economic challenges 
encountered by families through the loss of income due to maternal deaths[5] and may even 
extend to infant/child morbidity and mortality due to the loss of a primary caregiver for 
surviving children, particularly in the first year of life.[6] 
Even in settings where advanced and specialized medical services are available, e.g. the 
United States, preterm birth remains a major public health problem;[7] although outcomes 
differ substantially in such settings (with a further widening in the difference gap the earlier a 
child is born) compared to settings lacking advanced medical services.[3] For example, advances 
made in treating preterm babies – such as the administration of surfactant therapy to treat 
respiratory distress syndrome -  have contributed to  differences in survival between preterm 
babies born in low income countries compared to high income countries.[8, 9]  
Etiologically, preterm birth may result from spontaneous onset of labor or premature 
rupture of membranes (PROM), or be medically indicated, which is when a baby is delivered 
preterm (regardless of delivery type) due to medical complications affecting mother and or 
child.[10] Spontaneous onset of labor and PROM preterm births are usually grouped together 
and referred to as spontaneous preterm birth.[11]  Blencowe and colleagues reported that 
global estimates of the percent of spontaneous and indicated preterm births are not made due 
to unavailability of data;[12] but reports from previous studies conducted in either black or 
white populations in the United States indicate that spontaneous preterm births may account 
for approximately 75% of preterm births occurring among singleton pregnancies.[13] 
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According to the World Health Organization (WHO), preterm birth may be classified into 
three categories based on gestational age, namely: extremely preterm (delivery before 28 
weeks of gestation), very preterm (28 and before 32 weeks) and moderate to late preterm (32 
and before 37 weeks).[14]  Extremely preterm births account for the smallest number of cases, 
estimated at 5.2 percent, while the majority of preterm birth cases occur in the moderate to 
late preterm birth category, estimated at 84.3 percent. [12]  However, the most severe 
outcomes of preterm birth, regardless of setting, occur more frequently among extremely 
preterm babies.[11] 
Globally, preterm birth rates range from 5-18 percent;[3] the highest regional preterm rates 
in 2010 were in Southeastern Asia, South Asia, and sub-Saharan Africa.[12]  Preterm birth rates 
have increased for a number of regions in the preceding decades and are projected to continue 
to increase. [3] Factors such as improvement in ascertainment of gestational age,  and increase 
in rates of risk factors among childbearing women such as advanced maternal age,  chronic 
medical conditions, use of fertility treatments,  and increased use of caesarean section have 
been implicated in the increase in preterm birth rates.[14] 
 
1.3 Risk Factors 
A number of risk factors have been associated with preterm birth but the specific causes of 
preterm birth are not completely understood. Maternal factors including age, infection 
(especially reproductive tract infection), smoking, high and low body mass index (BMI), race, 
chronic conditions and obstetric characteristics such as previous preterm birth and short 
cervical length are established risk factors for preterm birth.(Reviewed in [7])  Socio-economic 
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factors, (reviewed in [15]) and air pollution [16-18] have been associated with preterm birth as 
well. Inflammation has been implicated in the mechanistic pathway between a number of these 
risk factors and preterm birth. [11]  
 
1.4 Inflammation and Preterm Birth 
Inflammation plays important roles in normal physiologic processes, but it is also associated 
with pathology. The inflammatory pathway is reported to be influenced by reproductive tract 
and systemic infections, [19] as well as other factors such as the direct [20]) and indirect effects 
of environmental pollution.[21] Pregnancy, independent of lower reproductive tract infection, 
is also associated with inflammation.[22, 23] Pathologic expression of inflammatory markers 
released in response to exogenous stimulants (particularly reproductive tract infection) has the 
potential to initiate preterm labor.[24] Released inflammatory markers (including cytokines) 
can activate the fetal and maternal membranes to produce prostaglandin and other 
substances.[25] Prostaglandin subsequently induces labor through its roles in cervical ripening, 
initiating uterine contractions, and the rupture of membranes.[26] 
Although reproductive tract infections play a major role in preterm birth etiology, and 
treatments have been shown to be effective in clearing lower genital tract infection during 
pregnancy, [27] interventions involving medically indicated and even prophylactic treatments 
for the prevention of preterm birth have had mixed results. Results have ranged from 
beneficial, [28, 29] to no effect, [30, 31] and in some cases treatment even appeared to be 
associated with adverse outcomes, [32, 33].  Reviewing the literature as a whole, antibiotic 
administration for the treatment of genital tract infection has not had an overall impact in 
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reducing preterm birth rates.[34, 35] The lack of success in preventing preterm birth has been 
attributed to differences in the mechanisms of action of antibiotics administered, timing, [36] 
and route of administration of antibiotics[37].  However, in some instances, eradication of 
bacteria may be insufficient to reverse the damage caused by the initial infection.[38] What is 
not clear is the mechanism by which the inflammatory effects of infection are perpetuated 
following antibiotic treatment. Perpetuation of effects may be due to an inflammatory cascade 
set in place at the time of infection; currently, it remains unclear whether this cascade is 
modifiable after initiation. 
The involvement of inflammation in both physiologic and pathologic processes has made it 
difficult to isolate the particular characteristic(s) of inflammation that define(s) the transition 
from physiologic to pathologic. This highlights a need to further understand inflammation 
during pregnancy, and its role in pregnancy duration.       
1.5 Cytokines During Pregnancy 
The physiological processes associated with pregnancy may lead to changes in the 
expression of pro and anti-inflammatory cytokines at different points during gestation. [22, 39, 
40] Inflammatory biomarkers such as cytokines are increasingly evaluated, albeit cross 
sectionally, as  indicators of the state of inflammation; they may be used as potential 
candidates for predicting preterm birth in part because of their ability to reflect immunologic 
response to both infectious and non-infectious activities.[22]  Amniotic fluid presents an 
opportunity to directly assess the inflammatory state to which the fetus is exposed. However, 
the invasive nature of obtaining amniotic fluid samples (amniocentesis) makes this option not 
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feasible for routine research purposes. Many research studies have therefore focused on the 
use of peripheral blood or cervico-vaginal fluid as proxies of inflammatory processes that occur 
during pregnancy.[41, 42] However, few of these studies evaluate cytokine concentrations over 
the course of gestation.[43] Cytokine quantification can be expensive [44] and this cost is 
assumed to play a major role in the number of cytokines evaluated in any given study. 
1.6 Research Setting and Data 
Mexico City is a densely populated[45] mega-city where distinctive geographical 
features and manmade combustion sources contribute to high air pollution levels.[46]  Because 
air pollution reportedly influences inflammation levels, [47, 48] Mexico City provides an 
appropriate setting to examine if and how air pollution influences systemic and lower 
reproductive tract  inflammation, and the association between cervical inflammation and 
preterm birth. 
This research uses data from a longitudinal study conducted among pregnant women in 
Mexico City, the Air Pollution and Birth Outcomes Study.[49]  The study has approximately 
monthly data on 20 inflammatory markers obtained from cervico-vaginal exudates and 
peripheral blood, repeated measures of clinical, microbiological, and behavioral data, and data 
on birth outcomes The combination of 20 cytokines and monthly repeated measurements is 
rare in prenatal research on inflammation.   Therefore this study provides a unique opportunity 
to describe cytokine concentrations over the course of pregnancy and to evaluate how 
longitudinal data on several cytokines may be used to predict preterm birth.  
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1.7 Summary and Specific Aims 
Although survival prognosis for preterm infants has improved [26] - more so in some 
areas compared to others[3] - efforts aimed at reducing the incidence of preterm birth have not 
had a major impact on preterm rates. The goal of this dissertation is to provide additional 
information that will improve our understanding of the role that inflammation plays during 
pregnancy, and how this information may be used to help identify those at risk for preterm 
labor/delivery. Due to the richness of the cytokine data, the findings will inform how 
reproductive tract cytokine levels can be used to predict preterm birth in a population exposed 
to higher than normal levels of air pollution, and provide information about how longitudinal 
information can be used to inform cross sectional studies.  
 The specific aims of this dissertation are: 
1. To characterize cervico-vaginal cytokines obtained longitudinally during the course of 
gestation and describe cytokine patterns among women who delivered term babies. 
2. A) To evaluate differences in concurrently measured systemic and reproductive tract 
cytokines among women who delivered at term.  B) To evaluate the associations 
between air pollution on serum, and cervico-vaginal cytokines among term births. 
3. To compare cytokine expression between women who subsequently delivered term and 
preterm babies.  Also, to simultaneously evaluate the association between cervico-
vaginal cytokines measured at different points in pregnancy and preterm birth.  
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Chapter 2 
Inflammation During Pregnancy:  Characterization of Cervico-Vaginal Cytokines in Term Births 
Using Longitudinal Data 
 
Miatta A. Buxton, Noemi Meraz-Cruz, Brisa N. Sanchez, Betsy Foxman, Marie S. O’Neill, Carina J. 
Gronlund, Felipe Vadillo-Ortega 
 
2.1 Abstract  
Inadequately regulated inflammation during pregnancy is associated with preterm birth, 
but what is a pathologic departure remains to be defined.  We used repeated measures of 20 
cervico-vaginal cytokines among 181 term pregnancies in Mexico City (2009-2014) to describe 
the range of cytokine concentrations obtained during the course of term pregnancy.  
Concentration distributions differed more between than within cytokines. In every 
trimester, cytokines IL-1RA, IL-1α, and IL-8 consistently had high concentrations. Cytokine intra-
class correlation coefficients ranged from 0.48 – 0.83, with IL-1RA, IL-1α, and IL-8 levels varying 
by point in pregnancy. Spearman correlation coefficients among cytokine pairs varied but 
correlation directions were stable; 95.3% of the 190 correlation pairs remained either negative 
or positive at three points in pregnancy.  Mean longitudinal patterns of log-transformed 
cytokines from Tobit regression varied across cytokines but less within cytokines.   
Overall, mean concentrations of cervico-vaginal cytokines among term pregnancies 
were largely stable over time. The high cytokine concentrations among term pregnancies 
corroborate that pregnancy leads to an inflammatory state, and suggest that high versus low 
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cytokine categories, versus metrics of inflammation that incorporate ratios and functional 
properties, may be insufficiently specific for predicting preterm birth.  
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2.2 Introduction 
Preterm birth is a major cause of neonatal morbidity and mortality and can have lifelong 
sequelae.[1] Infection is a known risk factor,[2] and inadequately regulated inflammation 
during pregnancy has been associated with preterm birth,[3, 4] but what constitutes a 
pathologic departure remains to be defined.  Particularly lacking is a characterization of the 
range of normal variation in inflammation biomarkers during a ‘healthy’ pregnancy.  
Inflammation is an important and normal part of pregnancy. [5] For example, implantation and 
parturition are associated with inflammatory states similar to those found in pathological  
conditions[6, 7] while other points in  normal pregnancy are marked by controlled systemic 
inflammation [8] not influenced by infection. [9] However, inadequately regulated 
inflammation can lead to pathological states, including adverse pregnancy outcomes.[4, 10-13]  
Cytokines are proteins that regulate host response inflammatory response to infection and  
injury, both locally and systemically.[14]   Cytokines may be measured from multiple sources, 
including cervico-vaginal exudates, and these sources may reflect systemic or local processes. 
Cytokine actions are usually paracrine or autocrine but some cytokines (including interleukin 
(IL)-1, IL-6 and tumor necrosis factor alpha (TNF-α)) exhibit endocrine or systemic effects.[11, 
15]  
Cytokines have multiple functions (including the regulation of inflammation) and redundant 
properties.   Cytokines interact to produce effects, making the study of cytokines particularly 
challenging.[11, 16, 17]  Understanding the effects of these complex processes on pregnancy 
outcomes - such as modulations in immune activity during pregnancy to allow for acceptance 
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and subsequent development of the “non-self” fetus while simultaneously working to stave off 
infection - requires measuring multiple cytokines.[7, 18]  
Moreover, cytokine levels change with time corresponding to specific processes occurring 
during pregnancy. [6, 11, 19] Therefore, cytokines measured only once during gestation are 
unlikely to reflect variability in cytokine levels over time. [20]  Most previous studies are cross-
sectional.[21]  
To fill these gaps, our objective was to characterize trajectories and concentrations of 20 
cervico-vaginal cytokines during pregnancy among women delivering term babies. Cytokines 
were selected because they represent three important components of the inflammatory 
process, namely: pro-inflammatory, anti-inflammatory and chemotaxis; in addition the selected 
cytokines reflect those with previously reported associations with preterm births.  
 
2.3 Methods 
Study population  
This study uses data collected as part of an ongoing cohort of 907 pregnant women in Mexico 
City. [22]  The aim of the original study was to evaluate the association between air pollution 
and birth outcomes. The study was approved by the Institutional Review Board from the 
University of Michigan and ethics committees from Secretaría de Salud del Gobierno de la 
Ciudad de México (Mexico), and the School of Medicine of the National Autonomous University 
of Mexico (UNAM). 
Pregnant women 18 years or older who lived and/or worked in metropolitan Mexico City 
(Mexico City  and surrounding areas) who presented before 18 weeks of gestation (this 
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requirement was required for a specific study objective relating to confirmation of gestational 
age by ultrasound) and provided written informed consent were enrolled in the study between 
2009 and 2014. All participants agreed to attend monthly prenatal visits and all had singleton 
pregnancies. Clinical samples (blood, urine, cervico-vaginal exudates) and demographic 
information were collected during monthly visits. 
Gestational age was calculated using baby’s birth date and the first day of last menstrual period 
(LMP) based on reliable and accurate recall from the earliest available visit record or screening. 
This analysis was limited to the 181 participants who had term births on whom data from at 
least one visit was available at the time of analyses.  
 
Collection and processing of biological samples                                                                                                                                                       
 Cervico-vaginal samples collected at each visit were used for quantification of cytokines. 
The samples were collected using a Dacron swab which was rotated for 10 seconds in the 
cervico-vaginal section of the lower reproductive tract; samples were subsequently frozen at -
20o C. Infection status was determined by clinical exam and microbiological data.  
 
Cytokine quantification                                                                                                                                                                           
 A total of 20 cervico-vaginal cytokines (Eotaxin, Interferon gamma (IFNγ), IL-10, IL-
12p40, IL-12p70, IL-17, IL-1rα, soluble IL-2 receptor alpha (sIL-2rα), IL-1α, IL-1β, IL-2, IL-4,Il-6, IL-
8, Interferon gamma inducible protein (IP-10), monocyte chemoattractant protein-1 (MCP-1), 
macrophage inflammatory protein 1 alpha (MIP-1α), macrophage inflammatory protein-1 beta 
(MIP-1β), TNFα, and vascular endothelial growth factor (VEGF)) were quantified in monthly 
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cervico-vaginal samples using the Millipore MILLIPLEX® MAP human cytokine/chemokine 
magnetic bead panel kit (Millipore Corporation, Billerica, MA, USA) . The Millipore MILLIPLEX® 
MAP human cytokine/chemokine kit works by simultaneously quantifying several cytokines 
from a single sample. Per the manufacturer’s manual, the Milliplex MAP system uses the 
Luminex® xMAP® technology to color code microspheres with two fluorescent dyes to create 
distinctly colored bead sets, which are then coated with specific capture antibody.[23]  
This system generates a standard curve against which concentrations of cytokines in biological 
samples can be quantified.  Analyses were done in the laboratories of the National Autonomous 
University of Mexico or its affiliate, the National Institute of Genomic Medicine using previously 
frozen samples following the published protocol of the manufacturer.[23]  Analyses were done 
in duplicate for every cervico-vaginal exudate sample, and standard controls run as a basis for 
comparison.  
Thawed samples were briefly vortexed and centrifuged for 20-30 seconds and 25 µL of thawed 
cervico-vaginal exudate samples were added to each well. 25 µL of previously mixed beads was 
added to each well and 200 µL of wash buffer was added to all wells before the addition of 
25µL of detection antibodies to each well.  25 µL streptavidin-phycoerythtin was subsequently 
added to the wells, washed twice and then run on MAGPIX® with XPONENT software for 
analysis.   
Cytokine concentrations are reported in picograms per milliliter (pg/ml). Per the manufacturer’s 
protocol, the minimum detectable concentration in pg/ml, intra-assay coefficient of variation 
(CV) %, and inter-assay CV % respectively for each cytokine are shown in Supplemental Table 
S2.1 in the appendix. 
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The percent of observations below the limit of detection (LOD) varied across cytokines and 
these observations were reported by the equipment as “<LOD value”, which differed by 
cytokine. These values were transformed as LOD/√2 in order to have a numerical value for 
subsequent analyses.   
In addition to values below the LOD, some samples had  high concentrations of cytokines that  
exceeded the upper limit of detection of the equipment, and could only be quantified as 
greater than a given value, e.g. “ > 10,000 pg/ml”, or extrapolated beyond the standard curve, 
without further sample dilution. For statistical analyses, these very high values were 
transformed by adding 10 pg/ml.  Data sets which have continuous values but on the lower end 
of the distribution take on constant values (e.g. LOD/√2) are referred to as ‘left-censored’; 
similarly, ‘right-censored’  is a  term used to describe constant values (e.g. 10,010 pg/ml) at the 
upper end of the distribution.  Appropriate statistical methods must be chosen that account for 
such censored data; this censoring is a common characteristic of cytokine data. [24]  
 
Statistical Analysis  
Statistical analyses were performed using SAS Statistical Software version 9.3 (SAS 
Institute Inc. Cary, NC, USA) and R version 3.2.2 (R Foundation for Statistical Computing, Vienna, 
Austria). Descriptive statistics on demographic and obstetric/gynecologic characteristics were 
generated to describe the sample of study participants.  Probability of infection for each 
trimester was determined by calculating the mean across all participants of (number of 
infections per trimester for each participant/number of visits per trimester for each 
participant).  The distribution of each cytokine was examined using histograms and q-q plots.  
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For descriptive purposes and to gain insights into how cervico-vaginal cytokine concentrations 
varied across time, we calculated concentrations of cytokines at given percentiles of all 
observations for each cytokine by trimester. In addition to being sometimes left and right 
censored, some of the cytokine concentrations were not normally distributed.  Therefore, we 
used empirical cumulative distribution functions (ECDF) to graphically represent the 
distributions for each cytokine by select months of gestation. The cenfit function from the 
NADA package in R was used to generate ECDF plots.  Cenfit uses the Kaplan-Meier method on 
left censored data that have been automatically “flipped”  by the NADA package to compute 
ECDFs and appropriately displays the part of the distribution where information is lacking due 
to values below the LOD.[25]   
Spearman correlations were calculated for pairs of cytokines for each trimester, using 
the LOD/√2 substitution for values below the LOD, and the upper LOD plus 10 pg/mL 
substitution for values above the upper LOD.  The correlations were graphically illustrated by 
the use of heat maps. [26, 27] A correlation heat map  is a visual presentation of data from a 
correlation matrix  wherein  darker colors reflect stronger (closer to 1 or -1) positive or negative 
coefficients and lighter shades reflect coefficients of lesser magnitude.[28]  To separate the 
influence of correlation within women due to repeated measurements, Spearman correlation 
coefficients were computed using cytokine concentrations from the gestation month with the 
highest number of observations for each trimester.  To enhance interpretability of the heat 
maps, the ordering of cytokines on the axes was based on functional groups.   P-values for 
correlations were adjusted to control the false discovery rate.[29] 
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We also calculated intraclass correlation coefficients (ICCs) for each cytokine. ICCs are 
calculated to quantify reproducibility (stability) of cytokine concentrations within participants 
across the duration of pregnancy. ICCs are commonly obtained by fitting a random intercept 
model to the repeated measures from participants, assuming normally distributed data; log-
normality is often assumed for highly skewed variables and log transformations are taken prior 
to ICC calculations. These conventional analyses are not fully appropriate for our data for two 
reasons: the cytokine distributions were right- and left-censored as described previously, and a 
number of the cytokines were not normally distributed even after log transformation. To 
address lack of normality, we applied the Box-Cox transformation [30]  technique to the 
cytokine with the lowest percent of observations below the LOD, and identified that an inverse 
fourth root transformation yielded distributions closer to the normal distribution; this 
transformation was applied to all cytokines. To address the censoring, we fitted models for 
repeated measures subject in SAS NLMixed; this procedure uses  maximum likelihood 
estimation to fit mixed effects models and accounts for left censoring of log-normally 
distributed data.[31] The NLMixed log transformed procedure was modified to account for the 
inverse fourth root transformation.  Because the distribution of the transformed data still did 
not appear completely normal, two ICCs were calculated for each cytokine using a combination 
of one statistical procedure and two data transformations to allow assessment of how robust 
the ICCs were to techniques for transforming data. The following techniques were used to 
calculate ICCs: NLMixed using log transformed,[31] and NLMixed using inverse fourth root 
transformed data. The resulting mean from the ICCs and standard deviation were reported for 
each cytokine.  
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Finally, we characterized cytokine patterns over time in women who delivered at term 
using Tobit regression (Survival package in R).[32]  Tobit regression is a parametric regression 
technique which properly accounts for both left and right censoring [33] and may be used for 
data with repeated measures.[34]   This kind of model is also called a censored regression 
model, and the purpose in this case is to estimate and plot the form of the relationship 
between time (gestational age in weeks in the x-axis) and mean cytokine concentrations (y-
axis), with their 95% confidence intervals.  The Tobit model takes the following form:  
E(ln (cytokineij)) = α + βgw gwij 
where α is the average cytokine level at the time of LMP (i.e., gestational week=0) and  
gwij is a set of variables representing a natural cubic spline parameterization of the gestational 
weeks at the time of the ith observation in the jth woman. A working independence assumption 
is used to fit the model, but robust standard errors of model coefficients are computed using 
the sandwich formula. We used the estimated parameters α and βgw to construct plots 
that illustrate mean cytokine patterns during the course of pregnancy by calculating  
ln⁡(𝑐𝑦𝑡𝑜𝑘𝑖𝑛𝑒𝑖𝑗⁡|⁡𝑡)⁡ =⁡ {𝑎}̂ ⁡+ {𝛽𝑔𝑤}̂ t for a grid of values of t. 
 
Plots from Tobit regression models illustrate mean cytokine patterns during the course 
of gestation while the ECDFs as described above allow the generation of percentiles which can 
subsequently be plotted.  ECDF plots graphically display the complete distribution of each 
cytokine concentrations for a given time point. Once the proper linear or non-linear form of the 
function between time and the cytokine concentrations for each cytokine is established in the 
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model, the Tobit model assumes that the model residuals are normally distributed.  This 
assumption was assessed using residual plots.  
 
2.4 Results  
The median gestational age at enrollment for the 181 participants was 12.4 weeks 
(range 7 – 25.4 weeks of gestation) and the median number of visits over the course of 
pregnancy was 4 (range 1-8).  Women were primarily in the 20-35 age group (70%) and most 
reported having had at least one previous child (54.7%). Most participants were either normal 
weight (33.2%) or overweight (32.6%) prior to pregnancy. The probability of clinician diagnosed 
reproductive tract infection was highest in the second trimester (0.37) and decreased in the 
third trimester (0.28) (Table 2.1).  
The percent of observations below the LOD, and above the upper LOD for each cytokine 
varied across pregnancy with no consistent pattern or trend in the monthly percentages. (Data 
not shown) For the lower LOD, most cytokines had an overall percent below the LOD between 
10%-30%. The majority of cytokines had less than 5% above the upper LOD, including five 
cytokines (IL-2, TNFα, IL-12p70, IL-17, and IFN-γ) with no observations above the upper LOD.   
The overall percent below the LOD and above the upper LOD as well as range in percent above 
or below for each cytokine, derived from gestational months, are reported in table 2.2. 
Cytokine concentrations were not normally distributed so log transformed values were used in 
analyses that required a normal distribution and indicated when this was the case; all other 
analyses used non-transformed cytokine values. 
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Percentiles of non-transformed cytokine values are presented in table 2.3.  
Concentrations differed across cytokines; three cytokines (one anti-inflammatory (IL-1RA) and 
two pro-inflammatory (IL-1α, and IL-8)) consistently had high concentrations for the median, 
75th, and 95th percentiles for all trimesters, while IP-10, and VEGF consistently had high 
concentrations at the 95th percentile across pregnancy but substantially lower concentrations at 
the 50th, and 75th percentiles.   Similarly, plots for all 20 cytokines for select gestational months 
(3, 5 and 7) presented in supplemental figures S2.1-S2.5, showed differences in ECDFs across 
cytokines but ECDFs did not differ across time for most cytokines. 
Using average intraclass correlation coefficients (ICCs) obtained from log transformed 
data and inverse fourth root data, many of the cytokines exhibited good reproducibility (ICC 
between 0.60-0.74) over the course of pregnancy (Table 2.4).  Across all cytokines, ICCs ranged 
from 0.48 – 0.83 (fair to excellent reproducibility).[35]  Although the ICCs estimated from the 
log transformed data differed numerically from the ICCs from inverse fourth root transformed 
data, in most instances, both estimates for each cytokine were within the same category except 
for 3 cytokines MIP-1β, MIP-1α and IL-1RA which moved across categories based on the data 
transformation type. 
Spearman correlations among the 20 cytokines illustrated in heat maps (figures 2.1-2.3) 
showed that correlation coefficients across pairs of cytokines varied over time but the direction 
of correlation was stable over the course of pregnancy.  95.3% of the 190 correlation pairs 
remained either negative or positive at the three points evaluated in pregnancy.  The strongest 
positive correlation at month 3 was 0.84 for pro-inflammatory pairs IL-12p40 and IL-2 (same for 
month 7) and INF-γ and VEGF, and the strongest positive correlation at month 5 was 0.81 for 
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pro-inflammatory pairs IL-1β and IL-1α. The strongest negative correlation at month 3 was -0.43 
for anti -inflammatory cytokine IL-1RA and pro-inflammatory cytokine TNFα (month 7 
correlation coefficient was -0.42) and the strongest negative correlation at month 5 was -0.52 
for anti-inflammatory cytokine IL-1RA and pro-inflammatory cytokine MIP-1β.  A total of 570 
Spearman correlation coefficients (190 for each time point) for months 3, 5, and 7, p-values and 
number of observations for each pair of cytokines are reported in supplemental Table S2.2 in 
the appendix. 
The mean longitudinal patterns of log transformed cytokines adjusted for lower 
reproductive tract infection status varied across cytokines, but little variability was observed 
within cytokines (Figures 2.3-2.8). Lower reproductive tract infection did not appear to 
substantially influence mean cytokine patterns as unadjusted patterns (figures not shown) did 
not differ from patterns adjusted for infection for most cytokines. Among the few cytokines 
that did change, subtle shifts in mean levels occurred for: IP-10* – slight decrease (*indicates 
borderline significance), and sIL-2Rα*, IL-10, TNFα, IL-17, and IL-1β – slight increase. (Data not 
shown) Mean levels were high throughout pregnancy for IL-1RA, IL-1α, IL-8 and these 3 
cytokines were the most variable compared to the other cytokines. They exhibited a pattern of 
slight decrease towards the end of the first trimester of pregnancy followed by a slight increase 
late in the second trimester (around week 25) and a decrease by the end of pregnancy.  INF-γ 
also exhibited some variability during the course of gestation but mean levels were lower 
compared to the other cytokines that were variable.  IL-4 and IL-1β shared a similar pattern, 
slightly decreasing by mid pregnancy and increasing by the end of pregnancy, but overall IL-1β 
levels were higher than IL-4.  The mean levels of most other cytokine including TNFα, IP-10, IL-
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10, sIL-2Rα, and MCP-1 remained stable across pregnancy; however, a few stable cytokines 
including Eotaxin, IL-2, IL-12p40, IL-12p70, IL-17, and IL-6 showed a slight increase toward the 
end of pregnancy. MIP-1α and MIP-1β were also stable but showed slight (MIP-1α) and very 
slight (MIP-1β) decreases at the end of pregnancy.   
 
2.5 Discussion  
This research used longitudinal data to describe individual characteristics, as well as 
joint relationships between pairs, of 20 cervico-vaginal cytokines among women who delivered 
at term in order to better understand the normal baseline of the trajectory of inflammatory 
processes during pregnancy, and how key biomarkers of these processes relate to one another. 
One critical finding was that lower reproductive tract infection adjusted mean concentrations 
varied by cytokine, but within individual cytokines, little to no variability in mean levels over 
time was observed. Even among cytokines that exhibited some variability in mean levels, the 
changes were gradual over time.   This suggests that cytokines measured at a single point in 
time during pregnancy may be representative of overall pregnancy levels. 
This study was conducted in a population of middle income women residing in Mexico City, so 
use of similar methods in other populations would be useful to characterize the inflammatory 
‘baseline’ among term pregnancies and determine if the patterns/findings from this population 
are generalizable. Even though cytokine concentrations in our study were within range of 
previously reported studies, [36-38] concentrations in this study were generally higher than the 
ranges frequently reported.  Infection is a known stimulant of immune activity so the finding 
that mean cervico-vaginal patterns were not substantially affected by infection was 
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unexpected. However, previous studies have had inconsistent results with findings of increased, 
no difference, or decreased levels of cytokines in the context of bacterial vaginosis. (Reviewed 
in [39])   It may be because pregnancy encompasses periods of varying severity of inflammation 
[5], infection did not further influence inflammation levels in this population.  This may also 
partly explain a lack of change in cytokine levels when adjusted for infection, as concentrations 
were already reflective of high levels that would otherwise (i.e. outside of pregnancy) indicate 
pathology.   
In contrast to the largely stable patterns over time within individual cytokines, the 
association between cytokines varied across pairs and the strength of correlation changed over 
the course of pregnancy for some cytokines.  However, the direction of the Spearman 
correlation coefficients remained stable for most cytokine pairs. Due to the variability in the 
Spearman correlations across cytokines, summary statements about correlation by functional 
groups (i.e. pro vs anti-inflammatory) cannot be easily made, but correlations that were 
significant and remained stable over time can potentially be used to inform associations 
between cytokine pairs across trimesters without having to obtain data for each time point.   
Additionally, cytokines in this study exhibited fair to excellent reproducibility over time, 
regardless of the type of data transformation used. Of note is that 4 of the 6 cytokines with 
mean ICCs indicating fair reproducibility were chemokines IL-8, IP-10, MCP-1 and MIP-1α (the 
two exceptions were IL-6 and VEGF). A cutoff category of fair indicates that these cytokines 
exhibited some degree of variability within participants across the study sample and may be 
reflective of frequent expression of chemokines for the many different roles in which they are 
reportedly involved. Chemokines are multifunctional cytokines that are involved in activating 
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and directing the movement of cells of the immune system in response to infection and injury; 
they are also reported to be involved in cellular differentiation, placental development, and the 
balance between immune-efficiency and immune-tolerance in the presence of the developing 
fetus. [40-42] Since both up and down regulation of chemokines are needed for these 
processes to occur, this provides some insights regarding why reproducibility for each of these 
chemokines is lower compared to other cytokines. Interestingly, although not a chemokine, IL-6 
essentially acts as a chemokine due to reported chemotactic activities [43] on T-cells [44] and 
monocytes [45]. This also may in part explain the lower ICCs for IL-6 due to frequent 
upregulation or least changes in expression due to its dual involvement in proinflammatory and 
chemotactic activities. 
The role of pro-inflammatory and anti-inflammatory cytokines in pregnancy - especially 
their potential influence on the length of pregnancy - is an important topic which is being 
increasingly evaluated in studies.  However,  a dearth of longitudinal studies describing cervico-
vaginal cytokine patterns over the course of pregnancy [21] highlights a need for 
comprehensive studies describing what may be regarded as “normal” immunologic responses 
to pregnancy.  A search of the literature found very limited information on longitudinal cervico-
vaginal cytokine patterns among persons who delivered at term. Donders et al. evaluated - 
among 92 women in Leuven, Belgium - whether six vaginal cytokines (IL-6, IL-8, IL-1β, IL-IRA, LIF 
(Leukemia inhibitory factor), and TNFα) varied during the course of uncomplicated pregnancy 
(n=30) and further compared trimester specific cytokine distributions to non-pregnant 
participants (n=62). Cytokine concentration ranges were different in this study compared to 
ours so comparison between the two studies will focus on patterns. Similar to our results, 
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Donders et al. reported a slight decrease in mean concentration of IL-1β between the first and 
second trimesters followed by a slight increase during the third trimester.  IL-6 levels were low 
with an increase at the end of pregnancy in both studies, but Donders et al. showed a steeper 
increase. Although greatly different numerically in terms of concentrations, patterns were 
similar for IL-8 until the very end of pregnancy where we showed a decrease not seen in 
Donders at al. This may reflect true differences between the studies or might be influenced by 
the availability of data points up to 40 weeks in our study whereas Donders et al. collected data 
up to 38 weeks of gestation.  Finally, mean levels of TNFα were low, and IL-1Ra showed 
variability over time in both studies, but IL-1RA patterns were different. 
Heng et al. reported IL-1β and IL-1RA profiles among 153 women in Heidelberg, Victoria, 
Australia.  In analysis of the 65 term pregnancies at 24-35 weeks of gestation, no linear trend in 
IL-1β levels as gestational age increased was seen, but a weak increasing trend was noted for IL-
1RA. Although we did not specifically evaluate for trend, our findings are similar in that, overall 
both cytokines were reported to have a consistent expression during the second half of 
pregnancy (prior to labor).  IL-1β and IL-1RA were significantly correlated in Heng et al. and our 
study.  By contrast, in a study of 119 women, Tanaka et al. reported significant increases in IL-
1β and IL-8 as gestational age increased among women in the second and third trimesters who 
were not in labor (n=65).[46] The reasons for these differences are unclear and warrant further 
investigation. 
Information on correlations among cervico-vaginal cytokines in term births was limited 
in previously published work; the few studies identified primarily focused on correlations 
between cytokines, but in the context of infection and/or race; [47] or other pregnancy 
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characteristics such as age, [36] cervico-vaginal fetal fibronectin,[48] and body mass index 
stratified by lower reproductive tract infection status.[49] However, in rare instances, 
correlations between cytokines for select points in pregnancy were identified. [46] Therefore, 
this work fills a specific gap about the relationship between pairs of cytokines over the course 
of pregnancy. 
From the results presented here, it appears that “normal” immunologic response to 
pregnancy encompasses a range of inflammation levels (not necessarily indicative of pathology) 
and that the more important aspect of inflammation in terms of adverse pregnancy outcomes 
may be deviations from a balanced state/homeostasis. 
Although the ability to evaluate pairwise correlations at multiple points in gestation is a 
strength of our study, but the complexity and temporal cascades of the inflammatory process 
and the multiple overlapping functions that cytokines play are important considerations for 
future studies.  Much of the literature addressing the possibility of using biomarkers as 
potential predictors of preterm birth relies on concentrations in biological samples taken at one 
or more discrete time points in gestation.  Thus, evaluating these concentrations over time and 
within and between cytokines exploits available data to provide insights into patterns and 
relationships that signify non-pathological inflammatory processes and could be later 
complemented by additional analytic approaches, data permitting. 
Our study was somewhat limited as the percent of cytokines below the limit of 
detection was high – although comparable to other studies evaluating inflammatory markers 
where the percent below the LOD for a number of cytokines was as high or higher. [50, 51]  
When evaluated using monthly data, no consistent trend over time was observed, and this 
 30  
 
indicates that lack of observed cytokine values was not systematically linked to the stage of 
gestation. 
Another limitation is that our results represent a characterization of cytokines from the 
third month to the ninth month of pregnancy, as only two participants were enrolled in the 
prior to month three. Because the first trimester is in essence represented by data from month 
three of gestation (data are “left-censored with a limit of detection at month 3”); if early first 
trimester (especially months 1 and 2) represents a period of substantial variability in cytokines, 
our conclusions would need to be re-evaluated. Finally, evaluation of the role of infection on 
mean cytokine concentrations over the course of gestation was limited due to the lack of 
information on the type of lower reproductive tract infection.  
Among the strengths of this study is the use of statistical methods that appropriately 
account for data characteristics (i.e. observations below the limit of detection). Evaluating 
relations between pairs of cytokines with Spearman rank correlations properly accounts for left 
censored observations. Also, use of percentiles (50th, 75th, and 95th) to describe cytokine 
concentrations over time accurately reflects observed values with given substantial numbers of 
observations above the LOD (overall data).  Additionally, methods used to calculate ICCs 
(modified mixed effects models),[31] longitudinal patterns (Tobit regression),[33] and ECDF 
(Cenfit which uses Reverse Kaplan Meier)[25] all appropriately accounted for left censoring. 
However, Tobit regression was the only method that accounted for right censoring, and this 
represents a limitation of the study.  
In conclusion, variability in mean concentrations of cervico-vaginal cytokines obtained 
over the course of pregnancy was minimal among women who subsequently delivered at term. 
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These findings further understanding of cytokine patterns during the course of pregnancy and 
suggest that, even after accounting for lower reproductive tract infection status, information on 
cytokine concentrations from any given point in pregnancy is informative about concentrations 
over the course of pregnancy. These results are potentially useful for informing future studies 
evaluating cytokine levels during pregnancy, implying that multiple repeated measures are not 
necessary in all cases. Additionally, the finding of very high cytokine levels in term pregnancies 
further corroborates that pregnancy- independent of pathology/infection - leads to an 
inflammatory state. This is especially useful information to put in context for studies evaluating 
the role of inflammatory markers on pregnancy duration- that categorizing cytokines as high 
versus low cytokine may not be sufficient markers for preterm birth risk. Thus, other 
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Table 2.1. Demographic and Obstetric Characteristics of 
Mexican Women Delivering Term Births, 2009-2014 
(N=181). 
Age N (%) 
  <20 34  (18.8) 
  20-35 127 (70.2) 
  >35 20   (11.1) 
Pre-pregnancy BMI N (%) 
<18.5 kg/m2 9  (5.0) 
  18.5-24.9 kg/m2 60  (33.2) 
  25-29.9 kg/m2 59   (32. 6) 
  ≥30 kg/m2 31  (17.1) 
  Missing 22  (12.2) 
Parity N (%) 
  Nulliparous 51  (28.2) 
  Parous 99  (54.7) 
  Missing 31  (17.1) 
    
Reproductive Tract  
Infection Probability of infection* 
  Trimester 1 0.31 
  Trimester 2 0.37 
  Trimester 3 0.28 
* Mean of (number of infection per trimester/number of visits for 
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Table 2.2. Percent of cervico-vaginal cytokine concentrations below  the lower limit of 
detection (LOD) and above the upper LOD† based on the manufacturer's manual, 





Percent < Lower LOD Percent > Upper LOD 
Overall  Range Overall Range 
Anti-inflammatory 
 
        
   IL-1RA 8.3 19.7 15.1 - 28.6 19.6 15.8 - 25.0 
   IL-4** 4.5 41.9 35.4 - 50.7 0.8 1.4 - 2.1 
   IL-10 1.1 15.9 11.9 - 18.6 1.4 1.7 - 2.5 
   sIL-2rα 11.2 33.6 26.3 - 44.1 0.9 0.8 - 1.7 
   IL-12p40 7.4 40.7 33.9 - 57.1 2.9 2.3 - 4.2 
Pro-inflammatory 
 
        
   IL-1α 9.4 13.0 9.7 - 42.9 9.8 5.8 - 11.5 
   IL-1β 0.8 13.0 5.9 - 16.4 5.9 4.2 - 7.6 
   IL-2 1 26.5 20.3 - 30.6 0   -- 
   IL-6 0.9 11.6 6.7 - 14.8 3.2 2.3 - 4.2 
   IL-8** 0.4 0   -- 25.3 19.2 - 34.0 
   TNF-α 0.7 17.1 13.3 - 19.7 0   -- 
   IL-12p70** 0.6 21.5 12.5 - 32.3 0   -- 
   IL-17 0.7 28.3 19.2 - 32.9 0   -- 
   IP-10 8.6 3.8 0.8 - 5.7 6.9 5.7 - 8.2 
   IFN-γ** 0.8 29.2 10.2 - 51.6 0   -- 
   MCP-1 1.9 2.1 0.8 - 3.0 3.2 1.2 - 5.1 
   MIP-1α 2.9 16.3 10.8 - 28.6 2.5 1.7 - 3.4 
   MIP-1β 3 4.4 1.7 - 6.4 1.3 0.6 - 2.5 
   Eotaxin 4 11.9 7.6 - 16.3 0.4 0.6 -0.8 
   VEGF 26.3 22.4 14.3 - 26.1 5.9 4.0 - 8.2 
†All cytokine values greater than 10,000 (pg/mL), the upper limit of detection, were assigned a 
value of 10,010 
*Sample size varied monthly and small Ns at the end of pregnancy influenced the wide ranges. 
Number of visits ranged from 1-8. 















Cytokine P50 P75 P95 P50 P75 P95 P50 P75 P95
Anti-inflammatory
  sIL-2Rα 14       44               1,840    22             51             921             20             54               1,436          
  IL-4* 10       57               1,941    8               54             1,699          10             122             1,746          
  IL-10 5         14               98         5               17             412             5               18               382             
  IL-12p40 9         24               111       10             25             634             11             29               988             
  IL-1RA 4,219  7,043          10,010  4,087        7,654        10,010        4,674        9,178          10,010        
Pro-inflammatory
  IL-1α 1,162  2,799          10,010  784           2,310        10,010        690           2,486          10,010        
  IL-1β 82       1,011          4,285    47             871           9,750          44             538             10,010        
  IL-2 3         10               41         3               12             163             3               14               230             
  IL-6 11       31               344       11             28             534             10             22               1,905          
  IL-8* 2,440  10,010        10,010  1,442        7,189        10,010        1,408        10,010        10,010        
  TNF-α 3         10               321       4               11             312             4               12               498             
  IL-12p70* 1         5                 249       1               6               278             1               8                 233             
  IL-17 1         4                 80         2               6               165             2               6                 186             
  IP-10 154     612             10,010  248           648           10,010        254           619             10,010        
  IFN-γ* 1         11               408       3               13             358             3               15               575             
  MCP-1 102     402             4,563    135           428           7,363          143           568             8,371          
  MIP-1α 14       44               1,886    10             45             3,455          8               48               2,861          
  MIP-1β 25       67               1,106    26             67             1,754          28             74               1,945          
  Eotaxin 16       30               401       21             37             1,255          22             39               2,001          
  VEGF 145     318             10,010  133           251           10,010        128           254             10,010        
* More than 50% of observations missing
†N= number of samples
Table 2.3. Distribution of Cervico-vaginal Cytokine Concentrations (in pg/mL) in Term Births by Trimester (Number of 
samples = 902)
First Trimester (N†=88) Second Trimester (N=443) Third Trimester (N=371)
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Table 2.4. Intraclass Correlation Coefficients of Cervico-vaginal Cytokine 
Concentrations in Term Births (N=181), Mexican Cohort, 2009-2014. 
Cytokine Log Inverse Fourth Root Mean Standard Deviation 
Anti-inflammatory 
  IL-1RA 0.82 0.67 0.74 0.11 
  IL-4 0.76 0.75 0.76 0.01 
  IL-10 0.69 0.64 0.67 0.04 
  sIL-2Rα 0.68 0.71 0.70 0.02 
  IL-12p40 0.76 0.79 0.78 0.02 
Pro-inflammatory 
  IL-1α 0.74 0.68 0.71 0.04 
  IL-1β 0.69 0.64 0.67 0.04 
  IL-2 0.63 0.62 0.62 0.01 
  IL-6 0.59 0.50 0.55 0.06 
  IL-8 0.56 0.41 0.48 0.10 
  TNFα 0.62 0.62 0.62 0.00 
  IL-12p70 0.86 0.79 0.83 0.05 
  IL-17 0.71 0.65 0.68 0.04 
  IP-10 0.51 0.50 0.51 0.01 
  IFN-γ 0.78 0.78 0.78 0.00 
  MCP-1 0.51 0.45 0.48 0.05 
  MIP-1α 0.61 0.56 0.58 0.04 
  MIP-1β 0.68 0.58 0.63 0.07 
  Eotaxin 0.83 0.82 0.83 0.01 
  VEGF 0.58 0.45 0.52 0.09 
Blue font indicates the log transformed cytokine distribution closer to normal.Red font 
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Figure 2.1. Correlation heat map based on Spearman correlation coefficients for cervico-vaginal 
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Figure 2.2. Correlation heat map based on Spearman correlation coefficients for cervico-vaginal 
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Figure 2.3. Correlation heat map based on Spearman correlation coefficients for cervico-vaginal 
cytokines at month 7 of gestation. Darker colors indicate stronger negative (tan) or positive (blue) 
correlations. 
 




Figure 2.4. Longitudinal Cytokine Patterns from Tobit Regression models adjusted for infection 
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Pregnancy: Implications for Evaluating Environmental Contributors to Inflammation 
 
Miatta A. Buxton, Noemi Meraz-Cruz, Brisa N. Sanchez, Carina J. Gronlund, Betsy Foxman, 
Felipe Vadillo, Marie S. O’Neill 
 
3.1 Abstract  
Inflammation is associated with preterm birth. Reproductive tract infection and 
environmental toxicant exposures can stimulate inflammation. However, few studies have 
evaluated the associations between longitudinal measures of systemic and reproductive tract 
inflammation and environmental exposures. 
We quantified cytokines from cervico-vaginal exudates and serum obtained 
concurrently among 178 women with term pregnancies and estimated PM10 and carbon 
monoxide (CO) exposure. Serum and cervico-vaginal cytokines were compared using the 
Wilcoxon signed-ranks test and Spearman rank correlations for select gestational months. We 
used intraclass correlation coefficients (ICCs) to quantify reproducibility of cytokine 
measurements, and Tobit regression to estimate associations between air pollution and 
cytokines. 
Median cervico-vaginal levels of IL-6, Eotaxin, IP-10, MCP-1, MIP-1α, MIP-1β, and TNFα 
were higher than corresponding serum cytokines, significantly so for IL-6 and IP-10. Cervico-
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vaginal and serum cytokines were not correlated, but cytokines from the same fluid were 
correlated. ICCs for most serum cytokines were ≤ 0.40, while ICCs were higher in cervico-vaginal 
cytokines (range 0.52-0.83). IP-10 and Eotaxin had the highest ICCs for both cytokine sources. 
Adjusted for age and infection, PM10 was positively associated with serum cytokines lL-6 and 
MIP-1β but inversely associated with cervico-vaginal cytokine TNFα. CO was inversely 
associated with cervico-vaginal TNFα, MIP-1β and MCP-1.  
Inflammatory processes are compartment-specific.  Systemic inflammatory markers may 
provide information regarding immunologic processes and response to environmental 
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3.2 Introduction 
Pregnant women are exposed to environmental toxicants in the air, water, and diet, but 
few studies have evaluated the effect of these agents on pregnancy duration.[1]  Air pollution is 
associated with systemic inflammation [2, 3] and oxidative stress [4, 5].  Alveolar macrophages 
are believed to be one of the links between inhaled pollutants that lead to inflammation in the 
lungs, and the subsequent systemic inflammatory response [6] that may cross the placental 
barrier through hematogenous dissemination.[7] Additionally, air pollution has been posited to 
play a role in affecting maternal susceptibility to infection.[8-10] Air pollution has been 
associated with premature rupture of membranes (PROM) – rupture of membranes at least an 
hour before the start of contractions, [11] and an increase in preterm premature rupture of 
membranes (PPROM) – PROM which occurs before 37 weeks of gestation.[12] Reproductive 
tract infection is an established risk factor for PROM, PPROM and preterm birth.[13]   
The degree to which exposure to air pollution affects inflammatory markers is poorly 
understood.   A systematic review and meta-analysis of studies up to 2010 on inflammatory 
markers and preterm birth in asymptomatic women found that elevated levels of IL-6 obtained 
from amniotic and cervico-vaginal fluids, and  C-reactive protein from amniotic fluid but not 
plasma, were strongly associated with spontaneous preterm birth among asymptomatic 
women.[14]  However, a current limitation is identifying the relevant tissue for measurement, 
as it is uncertain whether systemic inflammatory markers and lower reproductive tract 
inflammatory markers in pregnancy reflect the same or different pathways. This is important 
for understanding the role of air pollution in local and systemic inflammation, and how air 
pollution might affect pregnancy outcomes through one or both inflammatory pathways.  
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Mexico City, a mega-city where distinctive geographic features and manmade sources 
contribute to high pollution levels,[15] represents an ideal setting to examine the effects of air 
pollution on inflammatory markers such as cytokines. The primary aim of this study was to 
compare serum and cervico-vaginal cytokine concentrations throughout pregnancy among 
women who delivered at term. A secondary aim was to evaluate whether air pollution 




Study participants were selected from women participating in the Air Pollution and Birth 
Outcomes Study, an ongoing longitudinal study based in Mexico City.[16]  Participants were 
women with singleton pregnancies who were followed at approximately monthly intervals.  In 
addition to other enrollment requirements [16], all participants signed an informed consent 
form; they were 18 years or older, and lived and or worked in Mexico City.  Women in the study 
agreed to provide clinical, microbiological, and behavioral data at each visit.  The University of 
Michigan Institution Review Board and the Ethics Committees from the Secretaría de Salud del 
Gobierno de la Ciudad de México (Mexico), and the School of Medicine of the National 
Autonomous University of Mexico (UNAM) granted approval for the study.  
 
To directly compare serum and cervico-vaginal cytokines, we included all women for 
whom we had cervico-vaginal and serum samples collected on the same date (n=104). This 
dataset was used for all analyses. The median number of visits was 3 for this dataset. 




We used air pollution data collected by the Mexico City Atmospheric Monitoring System 
known as SIMAT. [17]  SIMAT routinely collects air pollution information on carbon monoxide 
(CO), nitrogen dioxide (NO2), ozone (O3), particulate matter less than ten microns in 
aerodynamic diameter (PM)-10, PM 2.5, and sulfur dioxide (SO2).  Data are collected hourly by 34 
automatic monitors located throughout Mexico City and surrounding areas.   
We chose to analyze PM10 in micrograms per cubic meter (μg/m
3) and CO in parts-per-million 
(ppm), because each one represents a different type (particle versus gaseous) of air pollution 
and have been previously evaluated during pregnancy. (Reviewed in [18]) Additionally, PM10 is 
a more spatially homogeneous pollutant whereas CO varies more in proximity to combustion 
sources. We used daily averages for PM10 and CO estimated from the monitor nearest each 
participant’s address for the day before each clinic visit. Because all monitors did not collect 
information on every pollutant, when data from the nearest monitor were not available, data 
from either the second or third nearest  monitor were used.[19] The selection of an exposure 
window for air pollution estimates for the day prior was based on previous studies on the 
effects of air pollution on systemic inflammation which used the same  day or the preceding 24-
hour period prior to collection of blood.[3, 20]  We used average air pollution estimates for the 
day prior instead of the day of visit because the exact time of sample collection from study 
participants was not known.  
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Cytokine Quantification 
The Millipore MILLIPLEX® MAP human cytokine/chemokine magnetic bead system 
(Millipore Corporation, Billerica, MA, USA) was used to measure 15 pro-inflammatory, and 5 
anti-inflammatory cytokines  obtained from monthly serum and cervico-vaginal samples.[21] 
The Millipore MILLIPLEX® MAP system simultaneously quantify various cytokines from a single 
sample.[22]  We measured 20 cervico-vaginal cytokines (Eotaxin, Interferon gamma (IFNγ), IL-
10, IL-12p40, IL-12p70, IL-17, IL-1rα, soluble IL-2 receptor alpha (sIL-2rα), IL-1α, IL-1β, IL-2, IL-
4,Il-6, IL-8, Interferon gamma inducible protein (IP-10), monocyte chemoattractant protein-1 
(MCP-1), macrophage inflammatory protein 1 alpha (MIP-1α), macrophage inflammatory 
protein-1 beta (MIP-1β), TNFα, and vascular endothelial growth factor (VEGF).  If no value was 
detected for a cytokine, we used in the analysis a value less than the limit of detection (LOD) as 
determined by the manufacturer. The LODs varied for each cytokine, and undetected 
observations were substituted with LOD/√2 in all analyses. Observations at the upper limit of 
detection (> 10,000 pg/mL) were assigned a value of 10,010 for analysis. 
Statistical analysis 
The study population was first characterized using standard descriptive statistics.  The 
trimester specific probability of clinician diagnosed infection was estimated by taking an overall 
average of the number of infections per participant for each trimester divided by the number of 
visits the participant made during that trimester.  The Wilcoxon signed-ranks test, which 
evaluates whether the median difference between groups is zero, was used to compare 
cervico-vaginal and serum cytokine concentrations obtained from the same set of participants 
for gestational months 3, 5 and 7. Because of the very high percent of observations below the 
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LOD, especially among serum cytokines, only pairs of cytokines with 50% or more values 
observed were evaluated, as was done in a previous study by Vogel et al. [23] 
To determine the relationships between pairs of cervico-vaginal and serum cytokines 
across pregnancy we used Spearman rank correlations for select gestational months. The 
Spearman correlation coefficients were illustrated in heat maps with a color gradient to 
indicate the strength and direction of the association between cytokine pairs.[24]    
Intraclass correlation coefficients (ICCs) divide the between-person variance by the summed 
between- and within- and -person variances to measure reproducibility of cytokine 
concentrations within participants across the duration of pregnancy (i.e. a summary measure 
across participants of how similar cytokine concentrations are within each participant).  Values 
of the ICC < 0.40; 0.40–0.75; and ≥ 0.75 indicate poor; fair to good and excellent reproducibility, 
respectively.[25] The ICCs were calculated for each serum and cervico-vaginal cytokine using log 
transformed and inverse fourth root transformation. These transformations were previously 
identified using a Box-Cox procedure to accommodate the fact that our cytokine data was not 
normally distributed, a key assumption for ICCs (Buxton et al, unpublished data (Aim 1)). To 
calculate the ICCs, we used a maximum likelihood estimation for lognormally distributed data 
which accounted for values below the limit of detection. [26]  
Finally, we used Tobit regression to estimate associations of the air pollutants PM10 and 
CO with select cervical and serum cytokine levels.[27] Tobit regression accounts for both 
undetected values at the lower and upper ends of the data and can be used for repeated 
measures.[28]  False discovery rate (FDR) was used to adjust the p-values from Tobit regression 
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models to account for multiple testing; FDR addresses the concern that multiple comparisons 
could yield statistically significant associations ‘by chance’ .[29] 
3.4 Results 
The majority of participants were between 20-35 years of age and were either normal 
weight or overweight before the start of pregnancy (Table 3.1).  Most participants had 
previously given birth to at least one child. The probability of infection increased from the first 
trimester to the second trimester and then decreased in the third trimester. The median 
gestational age at enrollment was around 13 weeks of gestation.  
The percent of observations below the limit of detection (LOD) varied across cytokines 
and the variation was even greater across cytokine source (i.e. serum versus cervico-vaginal 
samples) (Data not shown). Due to this variability, especially among the serum cytokines where 
the percent below LOD ranged from 0-97.8%, (data not shown) further analyses were restricted 
to cytokines with at least 50% of observations above the LOD in both cervico-vaginal and serum 
samples. The seven cytokines that met this criterion were: IL-6, Eotaxin, IP-10, MCP-1, MIP-1α, 
MIP-1β, and TNFα.  
All cervico-vaginal cytokine levels were substantially higher than the corresponding 
serum cytokines, but significant median differences between cervico-vaginal and serum 
cytokines were found only for IL-6 and IP-10 across all months evaluated (gestational months 3, 
5, and 7) (Table 3.2).   
Serum cytokines showed poor to good reproducibility over the course of pregnancy. 
(Table 3.3a) Average ICCs for most serum cytokines were less than 0.40 indicating poor 
reproducibility, except IP-10 and Eotaxin which exhibited fair and good reproducibility, 
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respectively.[25] Reproducibility was better for the corresponding cervico-vaginal cytokines; 
ICCs values were higher and reproducibility ranged from fair to excellent (average ICCs 0.52-
0.83) Similar to serum ICCs, IP-10 and Eotaxin had the highest ICC values. (Table 3.3b) 
Overall and individually, and at every time point, cervico-vaginal and serum cytokines were not 
correlated, even between matching pairs (for example, serum IL-6 vs. cervico-vaginal IL-6). Heat 
maps are presented in figures 3.1-3.3.  Even for the few serum/ cervico-vaginal pairs with a 
statistically significant association, correlations were very weak.  By contrast, cytokines from 
the same biological compartment tended to correlate. The strongest correlations were among 
cervico-vaginal cytokines TNFα and MIP-1β for months 3 (rho=0.86), 5 (rho=0.89), and 
7(rho=0.92). (Data not shown) MIP-1α and MIP-1β had the strongest correlations among serum 
cytokines for all time points evaluated (rho = 0.76, 0.84, 0.77 for month 3, 5, and 7 
respectively).  
PM10 averaged 56.0 µg/m
3 (SD=21.8) and CO averaged 1.5 ppm (SD=0.5) across the 582 
days of observation. In Tobit models adjusted for age and infection status, air pollutants were 
positively associated with serum cytokine concentrations (table 3.4). PM10 was significantly 
associated (p-value < 0.05) with serum cytokines TNFα, IL-6, IP-10, MIP-1β, and Eotaxin; and CO 
was marginally associated with serum cytokine Eotaxin. On the other hand, PM10 and CO were 
negatively associated with cervico-vaginal cytokines. PM10 was significantly associated with 
TNFα, IP-10 and MIP-1β, while CO was significantly associated with all cytokines evaluated 
except IP-10 and Eotaxin. However, after controlling for the false discovery rate, PM10 was 
significantly associated with only IL-6 and MIP-1β from serum, and significantly associated with 
cervico-vaginal cytokines TNFα, while CO remained associated with TNFα, MIP-1β and MCP-1.  
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3.5 Discussion 
We compared cervico-vaginal and serum cytokines obtained over the course of term 
pregnancy and evaluated their associations with particulate and carbon monoxide levels 
measured on the day prior to specimen collection. The relationship between inflammatory 
markers from these two compartments is of fundamental interest in perinatal epidemiology 
because of important role inflammation plays throughout healthy pregnancy, and because 
dysregulated inflammation, in response to infection, oxidative stress, and other factors, is 
suspected to be involved in the pathology of preterm birth.  
Our first key finding was that serum and cervico-vaginal cytokines were not correlated, 
and cervico-vaginal cytokines concentrations were substantially higher than for the 
corresponding serum cytokines. These findings indicate that inflammatory processes are 
compartment specific, with little to no crossover between compartments, at least when 
evaluated at the same point in time. Vogel et al. also found no correlation between cervico-
vaginal and serum cytokines in a study of 57 pregnant women in Birmingham, Alabama with a 
previous preterm birth.[23] Similarly, cervico-vaginal and serum cytokines were not correlated 
among 26 post-menopausal women with and without vaginal symptoms.[30] This suggests that 
compartment-specific immunologic response is not an anomaly of pregnancy but rather a 
normal physiologic process across conditions and/or stages of life.   
Our second key finding was cervico-vaginal and serum cytokines had different 
associations with particulates and carbon monoxide, suggesting that the biological mechanisms 
associated with systemic versus localized immunologic response to air pollution and other 
environmental exposures leading to oxidative stress/inflammation may differ. Our finding 
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reinforces the importance of a recommendation by Ferguson and colleagues.  In a repeated 
measures study evaluating the association between exposure to six phthalates (estimated from 
urinary metabolites) and five systemic inflammatory markers during pregnancy (in 30 individual 
models), found only one significant and three marginally significant associations.   Ferguson et 
al. concluded that inflammatory markers from more specific sources might be important to 
evaluate the association between phthalate exposure and the subsequent inflammatory 
response that can lead to preterm birth.[31] 
These results have implications for studies using biomarkers to evaluate the effects of 
inflammation on pregnancy outcomes: namely, that inflammation measured from a source 
contiguous to the site of the developing fetus might be more representative of the 
environment to which the fetus is exposed, compared to inflammation measured in the 
systemic circulation.  Georgiou and colleagues, in a recent review of advances made in the use 
of biomarkers to predict preterm birth, also concluded that because of its compositional 
characteristic of being a mixture of secretions from gestational and reproductive tissues,  
cervico-vaginal fluid is ideal for consideration of biomarkers related to labor.[32] By contrast, 
biomarkers obtained from blood components (plasma and serum) have been reported to be 
non-specific due to peripheral blood availability across body tissues and the potential that these 
biomarkers are either diluted or lack information about the exact source from which 
inflammation originated. Conversely, cervico-vaginal fluid has been reported to better 
represent immunologic processes occurring in the genital tract and may be more specific and 
sensitive compared to systemic biomarkers. (Reviewed in [33]). Ideally, amniotic fluid would be 
a more specific source of the inflammatory milieu that the fetus is exposed to; but the invasive 
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nature of obtaining amniotic fluid precludes routine collection of samples for research 
purposes. Cervico-vaginal cytokine IL-6 was found by Jun and colleagues to significantly 
correlate with amniotic fluid IL-6 in women with PPROM, as such cervico-vaginal cytokines may 
serve as a low risk proxy for assessing upper reproductive tract inflammation.[34]  
The idea that cytokines obtained from serum/plasma are non-specific is supported by 
the ICCs obtained for serum cytokines in this study. Serum cytokines exhibited more variability 
compared to cervico-vaginal samples and this may be an indication of the myriad factors 
capable of influencing cytokine levels in the peripheral circulation. Interestingly, ICCs for the 
corresponding cervico-vaginal cytokines were higher for the same participants for samples 
collected at the same time, again suggesting different processes occurring during these same 
time points and that these processes are compartment specific. 
Increases in serum cytokines linked with air pollution were expected but the negative 
association with cervico-vaginal cytokines was initially surprising. However, considered in the 
context of the relationship between air pollution and preterm birth - which has been 
hypothesized to be through its effects on maternal susceptibility to infection [8-10] -insights 
into this mechanistic pathway begin to unfold.  Air pollution may act similarly to the posited 
role of cigarette smoke on lower reproductive tract infection, by suppressing immunologic 
response. This lowered state of inflammatory response could permit the ascent of pathogens 
from the lower to the upper reproductive tract.  Although inconsistent across studies and not 
well defined, the immunosuppressive effects of smoking have been associated with a decrease 
in response by lymphocytes to mitogen (a substance needed for the start of cell division[35]) 
and also with impaired chemotactic activities of polymorphonuclear leukocytes. (Reviewed in 
 59  
 
[36]) Leukocytes are producers of proinflammatory chemokines such as MIP-1a, MCP-1, and IP-
10; these cytokines are involved in recruitment of monocytes and macrophages which are 
producers of other pro-inflammatory cytokines.[37] Thus, it appears that cigarette smoke 
interferes with a major positive feedback loop system that involves activation and recruitment 
of cytokine producing cells; and this interference might be similar to the process occurring 
between air pollution and reproductive tract immunologic response in our study. Although the 
mechanisms associated with the opposite expression of cytokines from systemic and lower 
reproductive tract and air pollution are unclear and need to be further evaluated, one possible 
explanation is that immunologic response may vary by pollutant type and part of the body 
being evaluated, and may be categorized in two ways: direct or indirect. For example, response 
to physical coarse particles in the lungs is direct and is associated with the release of pro-
inflammatory cytokines [3] while remote locations such as the reproductive tract might operate 
through other reported “sequelae pathways” such as the suppression of certain cell types.[36]   
Finally, the use of inflammatory markers collected longitudinally on the same 
participants on the same dates to evaluate median differences, reproducibility, and correlation 
between local and systemic sources is a major strength of this study. However, some limitations 
should be considered. The data used in the study contained values below and above the LOD. 
Except for the Tobit regression models which properly accounted for all censored observations, 
(ICCs calculation only accounted for observations below the LOD) censored values were 
replaced with common substitution methods. Simple replacement methods are commonly used 
for censored data but are known to have limitations especially when the percent below the LOD 
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reaches 25%.[38]  Another limitation is that other sources of inflammation and anti-
inflammatory medication use were not accounted for.                                                       
In summary, in a sample of pregnant women based in Mexico City, longitudinal 
measures of reproductive tract and systemic cytokines behaved dissimilarly, and that their 
associations with estimated short-term air pollution exposure differed. Not only were these 
inflammatory associations with air pollution compartment specific, they were in the opposite 
direction.  Although systemic inflammation may provide information regarding immunologic 
processes, inflammatory markers obtained from peripheral blood are not specific and may 
represent different as well as remote processes and should not be used as proxies of lower 
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Table 3.1. Demographic and Obstetric 
Characteristics of Pregnant Women Delivering 
at Term (N=104). Mexico City, 2009-2014 
Age N (%) 
  <20 18(17.3) 
  20-35 75(72.1) 
  >35 11(10.6) 
Pre-pregnancy BMI N (%) 
<18.5 kg/m2 7(6.7) 
  18.5-24.9 kg/m2 36(34.6) 
  25-29.9 kg/m2 37(35.6) 
  ≥30 kg/m2 17(16.4) 
  Missing 7(6.7) 
Parity N (%) 
  Nulliparous 30(28.9) 
  Parous 58(55.8) 
  Missing 16(15.4) 
    




  Trimester 1 0.3 
  Trimester 2 0.37 
  Trimester 3 0.31 
* Mean of (number of infection per 



























Cytokine CVE  Serum                         CVE Serum CVE  Serum                         CVE Serum                         CVE Serum                         
IL-6 0.9 11.4 40.6 <LOD - 10,010 <LOD - 259.8 11.0 0.6 8.5 3.0 12.3 1.9
Eotaxin 4 16.3 9.2 <LOD - 10,010 <LOD - 286.8 19.7 29.6 23.1 23.8 24.8 24.4
IP-10 8.6 4.9 0 <LOD - 10,010   23.5 - 1,334 323.4 257.1 347.7 228.3 352.8 256.7
MCP-1 1.9 1.7 0 <LOD - 10,010 3.2 - 2,277 174.3 347.0 222.8 322.1 226.5 276.5
MIP-1α 2.9 12.4 11 <LOD - 10,010 <LOD - 1,166 13.1 29.1 16.5 76.3 7.6 53.2
MIP-1β 3 4 0.3 <LOD - 10,010 <LOD - 952.7 39.4 60.0 45.4 73.8 31.4 67.9
TNFα 0.7 11.9 1 <LOD - 6,405 <LOD - 278.9 9.6 11.2 9.2 16.1 6.6 15.3
Red font indicates borderline significance 
Bold text: p-values ≤ 0.05 from the Wilcoxon Signed Rank Test. Median difference was tested only for cytokines in which both sources had 
50% or more of observations above the LOD.
Range
Overall
Values greater than 10,000 (in pg/mL) were assigned a value of 10,010 
%  < LOD Median Median Median 
LOD/√2 was substituted for values below the limit of detection for each cytokine 
Lower LOD 
(in pg/mL)
Table 3.2. Lower limits of detection (LOD) and descriptive statistics for concurrently measured cervico-vaginal exudate 
(CVE) and serum cytokine concentrations (in pg/mL), during overall pregnancy and specific months in gestation, among 104 
pregnant women in Mexico City, 2009-2014.
Month 3 Month 5 Month 7Overall
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Table 3.3a. Intraclass Correlation Coefficients of Serum Cytokine 
Concentrations in Term Births 
Cytokine Log Inverse Fourth Root Mean Standard Deviation 
sIL6 0.28 0.13 0.21 0.11 
sTNFα 0.20 0.23 0.22 0.03 
sIP-10 0.57 0.59 0.58 0.01 
sMCP-1 0.38 0.33 0.36 0.04 
sMIP-1α 0.32 0.25 0.29 0.05 
sMIP-1β 0.24 0.24 0.24 0.00 
sEotaxin 0.71 0.69 0.70 0.01 
s prefix indicates serum cytokine 
 
 
Table 3.3b. Intraclass Correlation Coefficients of Cervico-vaginal 
Cytokine Concentrations in Term Births 
Cytokine Log Inverse Fourth Root Mean Standard Deviation 
cIL6 0.58 0.55 0.57 0.02 
cTNFα 0.61 0.54 0.58 0.05 
cIP-10 0.64 0.69 0.67 0.03 
cMCP-1 0.53 0.50 0.52 0.02 
cMIP-1α 0.57 0.54 0.55 0.02 
cMIP-1β 0.64 0.56 0.60 0.05 
cEotaxin 0.84 0.81 0.83 0.02 
c prefix indicates cervico-vaginal cytokine 
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Figure 3.1: Correlation map based on Spearman coefficients for cervico-vaginal and serum 















 Figure 3.2: Correlation map based on Spearman coefficients for cervico-vaginal and serum 
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Figure 3.3: Correlation map based on Spearman coefficients for cervico-vaginal and serum 



























TNFα IL-6 IP-10 MIP-1α MIP-1β MCP-1 Eotaxin
Overall s.d. of distribution 2.15 2.38 1.78 2.48 1.96 2.22 2.02
Betas and s.e. by pollutant
PM10  (per 10 mg/m
3) -0.18 (0.07) -0.09 (0.09) -0.11 (0.06) -0.13 (0.08) -0.12 (0.06) -0.08 (0.08) -0.11 (0.07)
CO (per 10 ppm) -0.92 (0.27) -0.56 (0.34) -0.01 (0.25) -0.64 (0.33) -0.59 (0.26) -0.74 (0.26) -0.32 (0.29)
Overall s.d. of distribution 1.12 1.7 0.71 1.72 0.92 0.59 1.02
PM10  (per 10 mg/m
3) 0.06 (0.03) 0.24 (0.07) 0.05 (0.02) 0.10 (0.06) 0.08 (0.02) 0.01 (0.01) 0.07 (0.03)
CO (per 10 ppm) -0.05 (0.11) 0.19 (0.30) 0.12 (0.08) -0.36 (0.24) -0.07 (0.08) -0.08 (0.05) 0.20 (0.12)
Air pollution data from nearest monitor
Bold and blue - marginally significant after adjustig for FDR
SD for serum and CVE calculated in SAS
Table 3.4. Standard deviation (s.d.) changes in seven log-transformed pro-inflammatory cytokines from cervico-
vaginal exudate (CVE) and serum and corresponding standard errors (s.e.) per 10 unit higher ambient air 
pollutant concentration near residence, 1 day prior to clinic visit. Results are from infection and age-adjusted 
Tobit regression models that account for censored cytokine concentrations and repeated measures within 104 
pregnant women residing in Mexico City, Mexico, 2009-2014.
Cervico-vaginal 
Serum
Given the wide range of the cytokines, we have interpreted them on the log scale.
Bold font = p-value ≤ 0.05 after adjusting for false discovery rate (FDR)
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Chapter 4 
Cervico-Vaginal Cytokine Concentrations During Pregnancy and the Risk of Preterm Birth: A 
Comparative Analysis 
 




Preterm birth remains a major cause of perinatal morbidity and mortality worldwide; 
inflammation is considered an important component in the disease pathway. However, results 
from cross-sectional studies on the association between inflammatory cytokines and preterm 
birth are inconsistent.  We fill this gap by characterizing expression of 20 cervico-vaginal 
cytokines at multiple time points among 12 preterm and 78 term births. 
Empirical cumulative distribution and Spearman correlations for select months were 
computed for each birth outcome. Categories of inflammatory state were compared by birth 
outcome using Fisher’s exact test. Finally, we used logistic regression to estimate the 
association between preterm birth and five types of cytokine measures collected during 
pregnancy. 
Inflammatory state was associated with birth outcome. Individual cytokines in the first 
trimester had the strongest associations with preterm birth. IL-1α was the only cytokine with a 
protective association across pregnancy. IL-1RA was positively correlated with other IL-1 
cytokines among term births but negatively correlated among preterm births: Rho for term vs. 
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preterm for months 3, 5, and 7 were: 0.37 vs. -0.49; 0.38 vs. -0.62; and 0.34 vs. -0.67, 
respectively. 
Differences in cytokine expression, and dysregulation of anti and pro-inflammatory 
cytokines among preterm births as early as the first trimester indicate deviations from immune-
regulatory homeostasis.  Processes leading to preterm birth can occur early in pregnancy, 
facilitating effective screening.  Future studies should consider homeostasis in cytokine 
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4.2 Introduction 
Preterm birth or delivery before 37 completed weeks of gestation is a major cause of 
perinatal morbidity and mortality. [1] Despite decades of research, a clear understanding of the 
causes of preterm birth has yet to emerge [2].  The burden of preterm birth is especially high in 
low- and middle-income countries where resources and specialized health services are limited. 
For example, a major difference in survival (10% versus 90%) exists between extremely preterm 
babies (born before 28 weeks of gestation)  in low income countries compared to high income 
countries. [3] Moreover, in some rural and resource-limited settings where the nearest health 
facility may be a considerable distance away, preterm labor may lead to delivery at home or in 
facilities under-equipped to handle obstetric complications, and may also contribute to 
maternal mortality.[4] Even in the United States where advanced and specialized medical 
services are available, preterm birth is the leading cause of infant mortality, and has annual 
rates at approximately 12 percent. [5, 6]   
A number of maternal risk factors - including behavioral, medical and socio-
demographic factors – are associated with preterm birth. [7]   However, interventions targeting 
some of these risk factors such as nutritional supplementation, prophylactic and medically 
indicated antibiotic treatments have had mixed results, and overall have failed to have a 
significant impact in reducing preterm birth rates. [6] Consequently, much remains to be 
understood regarding how these risk factors interact to influence preterm risk.     
Inflammation is one of four major pathways implicated in decidual activation that may 
subsequently lead to preterm birth. [6] Pro-inflammatory  cytokines such as  interleukin (IL)-1, 
IL-6, IL-8, tumor necrosis factor-alpha (TNF-α) or anti-inflammatory (e.g. IL- 1Ra, IL-4, IL-10), are 
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proteins involved in the body’s response to infection and injury.[8] They also are important 
indicators of infectious and non-infectious injury to the body even among persons who are 
asymptomatic. [9]  The physiological processes associated with pregnancy can moderate 
changes pro and anti-inflammatory cytokine expression; [9-11]  but deviations from expected 
patterns at a particular point in pregnancy may indicate pathologies that might lead to preterm 
birth. [12-16]   
However, available evidence on the association of cytokines with preterm birth is 
inconsistent; perhaps because studies are small, and vary in biomarker selection, sampling 
timeframe, and tissue assayed.   For example,  Simhan et al found that women with high anti-
inflammatory/low pro-inflammatory first trimester cervical cytokines were at higher risk of 
early spontaneous preterm birth  compared to women who had low anti-inflammatory/high 
pro-inflammatory or balanced levels. [17] Similarly, Smith et al. found that levels of pro-
inflammatory cytokine IL-6 obtained from vaginal samples were lower in women who delivered 
preterm compared to women who delivered full term. [18] By contrast, Goepfert et al reported 
higher mean concentrations of IL-6 in women who delivered preterm compared to term.[19] 
Similar inconsistencies have been noted in studies using serum/plasma samples. [20-22]  
Our study addresses some of the limitations in previous studies.  We used longitudinal 
data on 20 cytokines obtained from monthly cervico-vaginal samples to compare cytokine 
expression between women who subsequently delivered term and preterm babies.  We further 
used comparative analyses to evaluate how well cytokine measures from different points in 
pregnancy predict preterm birth.  
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4.3 Methods 
This study used data from a longitudinal study (enrollment 2009-2014) based in Mexico 
City whose primary objective was to evaluate the association between air pollution and birth 
outcomes.[23]  The research study received approval from the University of Michigan 
Institutional Review Board, and the ethics committees from the Secretaría de Salud del 
Gobierno de la Ciudad de México (Mexico City) and the School of Medicine of the National 
Autonomous University of Mexico (UNAM). 
Participants in the study were pregnant women with singleton pregnancies who resided 
and/or worked in Mexico City and surrounding areas. Participants were 18 years or older, 
enrolled before 18 weeks of gestation, agreed to attend approximately monthly prenatal visits, 
and provided written informed consent. Additional data such as clinical samples (blood, urine, 
cervico-vaginal exudates), behavioral, and demographic information were collected during 
monthly visits. Participants in this study included two groups, namely: group 1 included 
participants that had at least one visit, along with the corresponding cytokine data, for each 
trimester; and group two included all participants regardless of the frequency of cytokine data. 
 
Gestational age calculation 
Monthly gestational age of the fetus was calculated using the date of visit and the 
reported first day of the last menstrual period (LMP); gestational age at birth was calculated 
based on the infant’s date of birth and the first day of the LMP. Both calculations were based 
on reliable and accurate recall of LMP from data collected to screen for eligibility. 
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Collection of biological samples 
Cytokines were quantified from cervico-vaginal samples collected at each visit. Samples 
were obtained using a Dacron swab rotated for 10 seconds in the cervico-vaginal section of the 
reproductive tract and frozen at -20o C for later processing. 
 
Quantification of cytokines 
The following cytokines were obtained from cervico-vaginal samples: Eotaxin, Interferon 
gamma (IFNγ), IL-10, IL-12p40, IL-12p70, IL-17, IL-1rα, soluble IL-2 receptor alpha (sIL-2rα), IL-
1a, IL-1β, IL-2, IL-4,Il-6, IL-8, Interferon gamma inducible protein (IP-10), monocyte 
chemoattractant protein-1 (MCP-1), macrophage inflammatory protein 1 alpha (MIP-1α), 
macrophage inflammatory protein-1 beta (MIP-1β), TNFα, and vascular endothelial growth 
factor (VEGF).  
Cervico-vaginal cytokines were selected instead of serum cytokines because we 
previously demonstrated that cervico-vaginal and serum cytokines were not correlated.  
Further, cervico-vaginal cytokine concentrations were higher than serum concentrations 
(Buxton et al, Aim 2). 
Cytokine quantification was done using the Millipore MILLIPLEX® MAP human 
cytokine/chemokine magnetic bead panel kit (Millipore Corporation, Billerica, MA, USA) based 
on the published protocol of the manufacturer. An advantage of the Millipore MILLIPLEX® MAP 
system is the concurrent quantification of several cytokines from a single sample.[24] Analyses 
were done in the laboratories of the National Autonomous University of Mexico or its affiliate, 
the National Institute of Genomic Medicine, using previously frozen samples. All analyses were 
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done in duplicate for cervico-vaginal exudate samples, and standard controls were run to serve 
as a basis for comparison.  
Data were left and right censored as the MILLIPLEX system is relatively insensitive at the 
lower and upper ends of the range of values. LOD/√2 (left censored) and a value of 10,010 
(right censored) were substituted for these observations in all analyses. 
 
Statistical analysis  
Trimester specific probability of infection was computed by averaging the number of 
infection diagnosed during a given trimester divided by the number of visits for that trimester. 
Fisher’s exact test and T-test were used to evaluate differences between term and preterm 
births. Cytokine distributions were evaluated using histograms to evaluate whether cytokine 
data needed to be transformed. Empirical cumulative distribution functions (ECDF) were 
calculated to illustrate month specific cytokine distributions by outcome. Plots were created 
using the cenfit and cendiff functions in NADA package in R.  Cenfit utilizes the Kaplan-Meier 
method for left censored data to compute ECDFs, and cendiff uses a Log-rank or Mantel-
Haenszel test for left censored data to evaluate the  difference between two or more 
ECDFs.[25]  Spearman Rank correlations for select months were calculated for each outcome 
group to separately evaluate the relationship between pairs of cytokines. Heat maps were 
generated to illustrate correlations between cytokines.[26] The p-values from the Spearman 
correlations were adjusted using Benjamini-Hochberg corrections for multiple testing.[27]   
We used Fisher’s Exact Test to evaluate if the ratio of pro-inflammatory to anti-inflammatory 
cytokines was associated with preterm birth, applying the method used by Simhan et al to data 
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groups 1(participants with at least one measure per trimester, N=90) and 2 (participants with 
varying degrees of follow up data).[17] The application of the same analysis on data groups 1 
and 2 was done to separate the effects of changing sample size (i.e. different subgroups of 
participants) by trimester on results. Specifically, data group 2 analyses were conducted to 
evaluate replicability of the results among participants that may be more representative of 
cohort data resulting from repeated measures studies.    
Trimester specific averages of each cytokine for each participant were computed, and 
each cytokine value was standardized by dividing by the interquartile range value of the 
cytokine due to the wide range of cytokine concentrations in this study. (Simhan et al used the 
medians of the cytokines).  The resulting values were summed and divided by the number of 
cytokines for each cytokine category (pro. vs. anti-inflammatory) to generate a score. The 
scores were divided into quartiles; those appearing in quartiles 1-3 were classified as low and 
quartile 4 as high. Women were then categorized into 3 groups, namely: high pro-
inflammatory/low anti-inflammatory, low pro-inflammatory/high anti-inflammatory, and the 
two other combinations were classified as balanced.  
Finally, comparative analyses were conducted using logistic regression to evaluate the 
association between preterm birth and cytokines measured at select points in pregnancy. 
Logistic regression models were fit for individual cytokine models for data group 1 using the 
following cytokine data as predictors of preterm birth: i. first trimester average, ii. second 
trimester average,  iii. third trimester average, iv. first, second, and third trimester averages 
combined in one model, and v. overall average. P-values from the logistic regression models 
were adjusted using Benjamini-Hochberg corrections for multiple testing.[27]  All analyses 
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included data up to month eight of gestation. All analyses were conducted in SAS 9.3 (SAS 




The median gestational age at enrollment was higher among term births than preterm 
births (11.2 weeks vs. 10.3 weeks); the median number of visits from enrollment to month 8 
was 3 for both groups.  Other than finding those delivering preterm were more likely to be 
nulliparous (p<0.05), we observed no statistically significant associations between demographic 
characteristics and preterm birth. (Table 4.1) 
Among term births, cytokine distributions varied little over time, but some variations 
over time occurred among preterm births (figures 1-10). For the majority of cytokines, women 
who delivered preterm had higher concentrations compared to the corresponding percentiles 
for women who delivered at term. IL-1α was the only cytokine with observations up to the 60th 
percentile that were statistically lower among preterm births compared to term births at all 
points evaluated. IL-1RA concentrations did not differ between groups but within the preterm 
group, shape of the distributions for IL-1RA and IL-1α appeared different. 
Patterns of correlations among cytokines were similar for months 3 and 7 for term and 
preterm births, but correlations were stronger among women who delivered preterm (figures 
11-16). Except for IL-1RA, IL-6 was positively correlated with all other cytokines at each time 
point with the exception at month 5 where among preterm, but not term births, IL-6 was 
negatively correlated with all cytokines. IL-1RA was positively correlated with other IL-1 
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cytokines (IL-1α and IL-1β) at all points among term births but negatively correlated among 
preterm births.   
By pro and anti-inflammatory ratios, the majority of participants had balanced cytokine 
levels, i.e. both pro-inflammatory and anti-inflammatory scores were high or both scores were 
low; but birth outcome was associated with inflammatory state.  This was true when limited to 
women with data at all time points (table 4.2a) and when all participants, regardless of number 
of samples, were included (table 4.2b).     
In logistic regression models, individual cytokines averaged across the first trimester had 
the strongest associations with preterm birth; 14 cytokines were either statistically significant 
or marginally significant after adjusting for multiple testing. Overall average models had 11 
estimates that were either statistically or marginally significant compared to 8 for second 
trimester concentrations. First trimester VEGF concentrations had the strongest association 
with preterm birth (odds ratio = 2.11; 95% CI 1.43, 3.10) and remained the strongest 
statistically significant predictor at other points during pregnancy (except for the 2nd and 3rd 
trimesters in the combined models). Although not statistically significant at every window 
evaluated, IL-1α was the only cytokine that exhibited a protective association across pregnancy. 
These analyses were conducted using the 16 cytokines where data were sufficient. Measures of 
cytokines IL-4, IL-8, INFγ, and IL-12p70 fell below the level of detection for >50% of 
samples.(Table 4.3)  Complete information on all models including combined trimester models 
are presented in supplemental table S4.1. 
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4.5 Discussion 
Ours is the first study that evaluated the associations of individual and groups of 
cytokines at multiple time points during pregnancy and risk of pre-term birth.  Patterns of 
cytokines were statistically significant different between term and preterm births.  Cytokine 
distributions appeared relatively stable throughout pregnancy among term births, compared to 
a more variable pattern for some cytokines among preterm births, notably, for preterm birth 
the production of cytokine IL-1α was low compared to IL-Ra.  
 The IL-1 family of cytokines represents a partially closed system that can potentially be 
used as a proxy for pro- and anti-inflammatory processes.  IL-1α and IL-1β are pro-inflammatory 
members of the IL-1 family while IL-1ra, which acts as an anti-inflammatory cytokine, inhibits 
the actions of both pro-inflammatory cytokines IL-1α and IL-1β by binding to cell receptors 
without activating cells.[13] In our previous analysis of term births, these cytokines appeared 
highly regulated, maintaining stable average levels throughout pregnancy, even after adjusting 
for infection. (Buxton et al, unpublished data (Aim 1)). An unbalanced production of IL-1α and 
IL-1β, and IL-1Ra is associated with diseased states. For example, Simhan et al reported strong 
associations (odds ratio 7.7 (95% CI, 4.9-9.1) between women with high anti-inflammatory and 
low pro-inflammatory first trimester scores and subsequent delivery before 34 weeks of 
gestation.  Even studies that did not specifically evaluate if IL-1α or IL-1β and IL-1RA 
concentrations were balanced have reported similar findings when pro-inflammatory cytokine 
levels were low. Kalinka et al reported strong associations between low levels of midgestation 
pro-inflammatory cytokines IL-1α and IL-1β and preterm birth among persons with lower 
genital tract infection.[28]   
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The hypothesized mechanism is that an impaired pro-inflammatory response permits 
lower reproductive tract pathogens to ascend to the upper reproductive tract, which might 
increase susceptibility to chorioamnionitis.[28, 29] Chorioamnionitis, or inflammation of the 
membranes (chorion, amnion and placenta), is a known risk factor for preterm birth and is 
associated with several maternal and neonatal adverse outcomes.[30]  
In contrast, high pro-inflammatory response with a corresponding low anti-
inflammatory response has also been associated with preterm birth.  Genc et al reported that 
low concentrations of IL-1RA and or high concentrations of IL-1β in response to colonization of 
the lower reproductive tract by select pathogens was associated with spontaneous preterm 
birth.[15] These studies and our study suggest that deviations from a balanced inflammatory 
state, rather than categories of high versus low cytokine concentrations might be potentially 
more specific in identifying pathologies that may lead to preterm birth. 
Supporting this idea, correlations between IL-1RA and IL-1α differed between term and 
preterm births. We found that IL-1RA was positively correlated with IL-1α at months 3, 5, and 7 
among term births in contrast to negative correlations seen among preterm births. The 
expression of these two cytokines in opposite directions between term and preterm births 
further supports the idea that dysregulation of the anti-inflammatory cytokine IL-1RA and pro-
inflammatory IL-1α is important in the pathology leading to preterm birth.  
The fact that several first trimester cytokines were predictors of preterm birth in this 
study is exciting. This suggests that processes occurring early on in pregnancy are potentially 
useful in identifying women at risk of delivering before 37 completed weeks of gestation and 
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may represent an opportunity for early intervention to possibly reduce the risk of preterm 
birth. 
Finally, several studies have previously evaluated associations between preterm birth 
and a small number of cytokines obtained from a single point during pregnancy.  Although 
some of these studies found associations between cytokine levels and preterm birth, results 
from these studies have been inconsistent with results ranging from null, associations with low 
levels, and high levels. [2, 18, 19, 31] The reason for these inconsistencies is not entirely clear 
but has been previously reported to be associated with factors such as biomarker selection, and 
sampling timeframe.[2]  Therefore, the simultaneous evaluation of up to 20 cytokines obtained 
monthly over the course of gestation from women who delivered at term and preterm is a main 
strength of this study.  
However, several limitations need to be considered; first, data for the first trimester are 
represented by month 3 data only due to almost all participants (except two) being enrolled at 
three months of gestation or later. Therefore, the first trimester estimates are actually 
estimates for the third month of pregnancy. One could only speculate how the month 3 
estimates would change when combined with data from months 1 and 2.  Second, the small 
number of preterm births limited our ability to adjust for known confounders. Although data 
were collected on infection status, parity, and body mass index, etc. all logistic regression 
models were adjusted only for age. Moreover, the small number of preterm birth precluded the 
evaluation of preterm birth by etiology.  Third, cytokine concentrations included left and right 
censored observations, and these were substituted with LOD/√2 and 10,010 respectively.  
Although substitution methods are commonly used in the analysis of data containing censored 
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observations, limitations have been reported when the percent above the LOD exceeds 
25%.[32]  
In conclusion, cytokine expression during the course of gestation differed between 
women who delivered at term compared to those who delivered before 37 weeks of gestation. 
Differences in cytokine expression and dysregulation of the anti and pro-inflammatory 
cytokines among women who delivered preterm were observed during the first trimester and 
indicate that problems or processes that potentially lead to preterm birth occur early in 
pregnancy. This implies that early dysregulation of cytokines could play a role in identifying 
women who may be at risk of preterm birth and may allow time for interventions to reduce 
preterm risks.  Future studies should therefore consider balance in cytokine expression when 
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Table 4.1. Demographic and obstetric characteristics of 
Mexican women who delivered term (N=78) and preterm 
babies (N=12), Mexico City, 2009-2014. 
Age Term N(%) Preterm N(%) 
  <20 13(16.7) 4(33.3) 
  20-35 52(66.7) 8(66.7) 




<18.5 kg/m2 2(2.6) - 
  18.5-24.9 kg/m2 23(29.5) 6(50.0) 
  25-29.9 kg/m2 27(34.6) 3(25.0) 
  ≥30 kg/m2 11(14.1) 1(8.3) 




  Nulliparous 19(24.4) 8(66.7) 
  Parous 45(57.7) 4(33.3) 
 Missing 14(18.0) - 
      
Reproductive Tract  
Infection 
Probability of infection* 
  Trimester 1 0.32 0.33 
  Trimester 2 0.33 0.44 
  Trimester 3 0.22 0.38 
* Average of (number of infection per trimester/number of visits for each 
participant per trimester) 
†
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Figure 4.1: Cumulative distribution functions of cytokines (IL-1RA and IL-1α) evaluated among 
term and preterm births at three time points during pregnancy among 90 Mexico City-based 
pregnant women, 2009-2014.  
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Figure 4.2: Cumulative distribution functions of cytokines (IL-1β and IL-10) evaluated among 
term and preterm births at three time points during pregnancy among 90 Mexico City-based 
pregnant women, 2009-2014.  
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Figure 4.3: Cumulative distribution functions of cytokines (IL-2 and IL-4) evaluated among term 
and preterm births at three time points during pregnancy among 90 Mexico City-based 
pregnant women, 2009-2014.  
 
 89  
 
 
Figure 4.4: Cumulative distribution functions of cytokines (IL-6 and IL-8) evaluated among term 
and preterm births at three time points during pregnancy among 90 Mexico City-based 
pregnant women, 2009-2014.  
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Figure 4.5: Cumulative distribution functions of cytokines (IL-12p40 and IL-12p70) evaluated 
among term and preterm births at three time points during pregnancy among 90 Mexico City-
based pregnant women, 2009-2014.  
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Figure 4.6: Cumulative distribution functions of cytokines (IL-17 and Eotaxin) evaluated among 
term and preterm births at three time points during pregnancy among 90 Mexico City-based 
pregnant women, 2009-2014.  
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Figure 4.7: Cumulative distribution functions of cytokines (MIP-1α and MIP-1β) evaluated 
among term and preterm births at three time points during pregnancy among 90 Mexico City-
based pregnant women, 2009-2014.  
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Figure 4.8: Cumulative distribution functions of cytokines (TNFα and VEGF) evaluated among 
term and preterm births at three time points during pregnancy among 90 Mexico City-based 
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Figure 4.9: Cumulative distribution functions of cytokines (MCP-1 and INFγ) evaluated among 
term and preterm births at three time points during pregnancy among 90 Mexico City-based 
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Figure 4.10: Cumulative distribution functions of cytokines (sIL-2Rα and IP-10) evaluated among 
term and preterm births at three time points during pregnancy among 90 Mexico City-based 
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Figure 4.11: Correlation map based on Spearman coefficients among cervico-vaginal cytokines 
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Figure 4.12: Correlation map based on Spearman coefficients among cervico-vaginal cytokines 
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Figure 4.13: Correlation map based on Spearman coefficients among cervico-vaginal cytokines 
for women who delivered at term using data from gestation month 7. 
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Figure 4.14: Correlation map based on Spearman coefficients among cervico-vaginal cytokines 
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Figure 4.15: Correlation map based on Spearman coefficients among cervico-vaginal cytokines 
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Figure 4.16: Correlation map based on Spearman coefficients among cervico-vaginal cytokines 
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Table 4.2a. Categories based on pro-inflammatory and anti-inflammatory 
ratio scores by outcome among 90 pregnant women in Mexico City, 
2009-2014 
Inflammatory State Term N(%) Preterm (N%) 
Trimester 1* 
High anti-/low pro-inflammatory  12(15.4) - 
High pro-/low anti-inflammatory  7(9.0) 5(41.7) 
Balanced  59(75.6) 7(58.3) 
  Trimester 2* 
High anti-/low pro-inflammatory  9(11.5) - 
High pro-/low anti-inflammatory  6(7.7) 4(33.3) 
Balanced  63(80.8) 8(66.7) 
  Trimester 3* 
High anti-/low pro-inflammatory  8(10.3) 1(8.3) 
High pro-/low anti-inflammatory  5(6.4) 4(33.3) 
Balanced  65(83.3) 7(58.3) 
*Fisher's Exact test p-value < 0.05 
Table 4.2b. Categories based on pro-inflammatory and anti-inflammatory 
ratio scores by outcome among pregnant women in Mexico City, 2009-
2014 using data with varying degrees of follow up across trimesters. 
Inflammatory State Term  N(%) Preterm N(%) 
Trimester 1* (N=98) 
High anti-/low pro-inflammatory  12(14.5) - 
High pro-/low anti-inflammatory  7(8.4) 6(40.0) 
Balanced  64(77.1) 9(60.0) 
  Trimester 2* (N=208) 
High anti-/low pro-inflammatory  21(12.8) 1(2.3) 
High pro-/low anti-inflammatory  8(4.9) 13(29.6) 
Balanced  135(82.3) 30(68.2) 
  Trimester 3* (N=188) 
High anti-/low pro-inflammatory  14(9.3) 1(2.6) 
High pro-/low anti-inflammatory  7(4.7) 7(18.4) 
Balanced  129(86.0) 30(79.0) 
*Fisher's Exact test p-value < 0.05 
 













Average Estimate OR (95% CI)
Cytokine N 1st 2nd 3rd Average
Eotaxin 90 1.40 ( 1.05, 1.87) 1.30 ( 0.99, 1.71) 1.18 ( 0.88, 1.57) 1.30 ( 0.97, 1.74)
IL-10 90 1.41 ( 1.07, 1.84) 1.34 ( 1.02, 1.74) 1.21 ( 0.91, 1.62) 1.37 ( 1.03, 1.83)
IL-12p40 90 1.40 ( 1.06, 1.84) 1.35 ( 1.03, 1.76) 1.25 ( 0.96, 1.62) 1.35 ( 1.02, 1.78)
IL-17 90 1.39 ( 1.04, 1.86) 1.30 ( 0.98, 1.74) 1.35 ( 0.99, 1.85) 1.38 ( 1.01, 1.89)
IL-1α 90 0.79 ( 0.61, 1.02) 0.72 ( 0.54, 0.97) 0.72 ( 0.54, 0.95) 0.69 ( 0.51, 0.94)
IL-1β 90 1.44 ( 1.07, 1.92) 1.35 ( 1.03, 1.76) 1.26 ( 0.99, 1.60) 1.40 ( 1.05, 1.87)
IL-1RA 90 1.02 ( 0.79, 1.32) 1.10 ( 0.81, 1.49) 1.01 ( 0.79, 1.29) 1.05 ( 0.78, 1.41)
IL-2 90 1.59 ( 1.14, 2.21) 1.55 ( 1.13, 2.13) 1.40 ( 1.01, 1.94) 1.61 ( 1.14, 2.29)
IL-6 90 1.76 ( 1.28, 2.42) 1.32 ( 0.97, 1.78) 1.43 ( 1.11, 1.83) 1.53 ( 1.13, 2.07)
IP-10 90 1.68 ( 1.19, 2.38) 1.62 ( 1.12, 2.34) 1.35 ( 0.96, 1.88) 1.66 ( 1.13, 2.43)
MCP-1 90 1.62 ( 1.17, 2.24) 1.31 ( 0.94, 1.82) 1.26 ( 0.94, 1.70) 1.45 ( 1.02, 2.06)
MIP-1α 90 1.63 ( 1.23, 2.16) 1.41 ( 1.09, 1.83) 1.27 ( 1.01, 1.61) 1.47 ( 1.12, 1.92)
MIP-1β 90 1.43 ( 1.05, 1.96) 1.28 ( 0.96, 1.70) 1.20 ( 0.90, 1.60) 1.32 ( 0.98, 1.78)
sIL-2Rα 90 1.39 ( 1.05, 1.85) 1.32 ( 0.97, 1.79) 1.22 ( 0.89, 1.66) 1.34 ( 0.97, 1.84)
TNFα 90 1.34 ( 1.04, 1.73) 1.32 ( 1.01, 1.72) 1.28 ( 0.97, 1.68) 1.38 ( 1.04, 1.84)
VEGF 90 2.11 ( 1.43, 3.10) 1.83 ( 1.29, 2.59) 1.49 ( 1.07, 2.09) 1.95 ( 1.34, 2.84)
Green font p ≤ 0.05 after False Discovery Rate (FDR) adjustment for multiple testing
Blue font ≤ 0.1 after FDR adjustment for multiple testing
Table 4.3. Adjusted* odds ratios(OR)  (95% confidence intervals) for preterm birth per log unit increase in 
cervico-vaginal cytokine concentration(pg/mL) from models† including one trimester alone (individual), and 
overall average (average), from a cohort  in Mexico City, 2009-14.
Individual Model Trimester Estimates OR (95% CI)
*Models adjusted for age
† Cytokine measures up to eight months were included in the models
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5.1 Research Overview and Implications 
Despite decades of research, preterm birth remains a public health problem of global 
significance with far reaching implications. These implications, which include permanent 
consequences such as long term morbidity and death, highlight that prevention rather than 
treatment of those with threatened labor is crucial in limiting the burden of preterm birth.   
Prevention is especially crucial in resource limited settings that lack the capacity (both in terms 
of medical personnel and facilities) to handle complications of pregnancy. However, even in 
resource rich settings, prevention is still important because treatment options for threatened 
labor [1] or for those at high risk have limitations, and subsequent preterm birth is associated 
with enormous medical and societal costs.[2]   
This dissertation evaluated systemic and cervico-vaginal inflammation during pregnancy 
by characterizing cytokines over the course of gestation and explored how such information 
may be used to identify persons at risk for preterm birth. The findings that gestational 
inflammation is essential for the successful progression of pregnancy, that mean cytokine 
concentrations were stable over time, and that first trimester cytokines were most frequently 
predictive of preterm birth are especially important for preterm birth epidemiology. Together, 
these three findings imply that there is potential utility in screening asymptomatic women to 
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evaluate for risk of preterm birth early in pregnancy.  Additionally, we found that inflammation 
from systemic and lower reproductive tract sources were not correlated, and were differently 
associated with air pollution exposure. This suggests that systemic cytokines may represent 
processes that are less specific than those occurring in the immediate surroundings of the fetus, 
and the protection provided to the developing fetus by gestational organs might make systemic 
inflammatory markers too imprecise for use in spontaneous preterm birth studies, or for 
studies linking oxidative stress from environmental exposures to adverse birth outcomes. 
 
5.2 Strengths and Limitations 
The use of monthly data on 20 inflammatory markers obtained from cervico-vaginal exudates 
and serum is a major strength of this study. The combination of cytokines from both systemic 
circulation and the lower reproductive tract, and frequency of measurement during gestation, 
is rare in inflammation research, and this provided a unique opportunity to simultaneously 
evaluate the effects of cytokines from different points during pregnancy in the same women.  
Additionally, analyses included methods that appropriately accounted for characteristics of the 
data, rather than dropping observations and losing information as is sometimes done.  
However, a number of limitations must be noted. First trimester data were limited due 
to an enrollment criterion that allowed participants to be enrolled up to eighteen weeks of 
gestation. Most participants enrolled during the third month of gestation; therefore the first 
trimester was represented by data from the third month of gestation. Also, although the 
inflammatory markers we measured were lower in the systemic circulation compared to the 
corresponding cervico-vaginal cytokines, other sources of systemic inflammation were not 
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accounted for in the evaluation of the association between air pollution and systemic 
inflammation. In addition, use of anti-inflammatory medication was not accounted for and this 
might have impacted cytokine levels in this population.  Finally, the low power resulting from 
the small number of preterm births precluded the evaluation of preterm birth by etiology, and 
the ability to control for known confounders of the association between inflammation and 
preterm birth.   
5.3 Future Research /Directions 
The observation that the direction of the association between air pollution and cervico-
vaginal inflammation was inconsistent with the expectation of increased inflammation levels 
requires further study. For now, these findings suggest that future studies should consider 
quantifying inflammation with a particular focus on the type of pollutant evaluated, as gaseous 
pollutants might operate through pathways that are different from particle-based pollutants. 
Specifically, a larger sample size will be required to evaluate these associations with 
appropriate statistical power, and to include the evaluation of both pro- and anti-inflammatory 
cytokines. 
Currently, cytokines are not routinely evaluated in prenatal care. The majority of 
preterm birth cases occur spontaneously among women who are asymptomatic (preterm labor 
resulting in preterm birth and preterm premature rupture of membranes (PPROM) account for 
up to an average of 75% of preterm birth cases in some populations in the United States [3]); it 
is in this group that efforts to reduce preterm birth rates should be aimed as it will most likely 
effect preterm birth rates.  
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Current strategies used to treat women who present with threatened labor usually 
prolong gestation briefly but not long enough to change delivery status from preterm to term, 
and thus have not had a major impact in reducing preterm rates.[1] Therefore, it is time for the 
focus to shift to screening of asymptomatic women before they become symptomatic. With 
earlier detection of risk, treatment and prevention strategies might be more effective in 
reducing preterm birth rates, and also minimize the adverse impacts of preterm birth. Even in 
instances where persons with identified risks are refractory to treatment, the identification of a 
health facility with specialized services (both in terms of clinical personnel and advanced 
treatment options) will potentially prevent some of the sequelae of preterm birth such as 
mortality for mother and child.  
Recommendations to screen asymptomatic women during the first trimester of 
pregnancy must consider the complexity of cytokines, and the costs associated with quantifying 
cytokines. Quantification of cytokines is expensive [4] and may play a role in the lack of interest 
in considering screening of asymptomatic women at least once during pregnancy. However, 
when compared  to the 26 billion in 2005 dollars in estimated cost associated with preterm 
birth in the United States alone,[2] and the unquantifiable burden associated with morbidity 
leading to a reduced quality of life, and loss of a mother and/or a child, the costs seems 
minimal. 
  Additionally, since cytokines are pleiotropic and redundant in action, and because 
quantification of cytokines is expensive, future studies should aim to evaluate cytokines that 
represent a summary of inflammatory processes – that is, select cytokines that can be used to 
assess deviations from a balanced system.  In this dissertation, we found differences in the 
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expected expression of IL-1 family cytokines anti-inflammatory IL-1RA and pro-inflammatory IL-
1α among term and preterm birth as early as the first trimester. These cytokines may represent 
a cost efficient opportunity to use only a minimal number of cytokines to screen for preterm 
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APPENDICES 
A. Table S2.1 Cytokine, the minimum detectable concentration in pg/ml, intra-assay coefficient 
of variation (CV) %, and inter-assay CV % respectively for each cytokine. 
 
Table S2.1. Minimal detectable concentrations, intra- and inter-assay coefficients of variation 
for 20 human cytokines/chemokines using a MILLIPLEX® MAP kit). [30]  
Analyte 
Lower 
LOD Intra-/ inter-assay CV Analyte 
Lower 
LOD Intra-assay CV 
Eotaxin  4.0 pg/ml ( 7.20% ,  10.8%)  IL-2  1.0 pg/ml ( 2.10% ,  6.3%) 
 IFNγ 0.8 pg/ml  ( 1.60% ,  12.0%)  IL-4  4.5 pg/ml ( 2.90% ,  14.2%) 
 IL-10  1.1 pg/ml  ( 1.60% ,  16.8%)  Il-6  0.9 pg/ml ( 2.00% ,  18.3%) 
 IL-12p40  7.4 pg/ml ( 2.80% ,  12.4%)  IL-8  0.4 pg/ml ( 1.90% ,  3.5%) 
 IL-12p70  0.6 pg/ml ( 2.20% ,  16.7%)  IP-10  8.6 pg/ml ( 2.60% ,  15.3%) 
 IL-17  0.7 pg/ml ( 0.70% ,  1.2%)  MCP-1  1.9 pg/ml ( 1.50% ,  7.9%) 
 IL-1RA 8.3 pg/ml  ( 2.10% ,  10.7%)  MIP-1α 2.9 pg/ml ( 1.90% ,  14.5%) 
 sIL-2rα 11.2 pg/ml ( 2.40% ,  8.0%)  MIP-1β 3.0 pg/ml ( 2.40% ,  8.8%) 
 IL-1α 9.4 pg/ml ( 3.30% ,  12.8%)  TNFα  0.7 pg/ml ( 2.60% ,  13.0%) 
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B.  Table S2.2. Spearman correlation coefficients, corresponding number of observations, and 
p-values adjusted for false discovery rate* for pairs of cervico-vaginal cytokines for months 
3, 5 and 7 of gestation for term births in Mexico City 
 
Table S2.2. Spearman correlation coefficients, corresponding number of observations, and p-
values adjusted for false discovery rate* for pairs of cervico-vaginal cytokines for months 3, 5 
and 7 of gestation for term births in Mexico City. 
    Month 3 Month 5 Month 7 
Cytokine 1 Cytokine 2 Rho N P-value Rho N P-value Rho N P-value 
cil4 cil10 0.52 31 0.00 0.48 73 0.00 0.55 53 0.00 
cil4 csil2ra 0.71 31 0.00 0.51 73 0.00 0.65 53 0.00 
cil10 csil2ra 0.66 86 0.00 0.67 157 0.00 0.79 122 0.00 
cil4 cil12p40 0.71 31 0.00 0.64 73 0.00 0.66 53 0.00 
cil10 cil12p40 0.65 86 0.00 0.65 157 0.00 0.66 122 0.00 
csil2ra cil12p40 0.79 86 0.00 0.67 157 0.00 0.66 122 0.00 
cil4 cil1ra 0.25 31 0.20 0.09 73 0.49 0.14 53 0.36 
cil10 cil1ra 0.08 86 0.53 0.06 157 0.52 0.00 122 0.97 
csil2ra cil1ra 0.05 86 0.67 0.15 157 0.07 0.09 122 0.34 
cil12p40 cil1ra 0.12 86 0.29 0.01 157 0.88 0.09 122 0.33 
cil4 cil1b 0.64 31 0.00 0.47 73 0.00 0.55 53 0.00 
cil10 cil1b 0.60 86 0.00 0.67 157 0.00 0.61 122 0.00 
csil2ra cil1b 0.62 86 0.00 0.48 157 0.00 0.55 122 0.00 
cil12p40 cil1b 0.77 86 0.00 0.63 157 0.00 0.64 122 0.00 
cil1ra cil1b 0.33 86 0.00 0.37 157 0.00 0.42 122 0.00 
cil4 cil1a 0.71 31 0.00 0.52 73 0.00 0.63 53 0.00 
cil10 cil1a 0.44 86 0.00 0.51 157 0.00 0.44 122 0.00 
csil2ra cil1a 0.41 86 0.00 0.38 157 0.00 0.41 122 0.00 
cil12p40 cil1a 0.64 86 0.00 0.52 157 0.00 0.54 122 0.00 
cil1ra cil1a 0.43 86 0.00 0.51 157 0.00 0.52 122 0.00 
cil1b cil1a 0.80 86 0.00 0.81 157 0.00 0.81 122 0.00 
cil4 cil2 0.66 31 0.00 0.69 73 0.00 0.63 53 0.00 
cil10 cil2 0.64 86 0.00 0.62 157 0.00 0.68 122 0.00 
csil2ra cil2 0.74 86 0.00 0.67 157 0.00 0.73 122 0.00 
cil12p40 cil2 0.84 86 0.00 0.71 157 0.00 0.84 122 0.00 
cil1ra cil2 0.03 86 0.77 0.04 157 0.61 0.11 122 0.27 
cil1b cil2 0.66 86 0.00 0.64 157 0.00 0.64 122 0.00 
cil1a cil2 0.52 86 0.00 0.45 157 0.00 0.54 122 0.00 
cil4 cil6 0.25 31 0.21 0.41 73 0.00 0.58 53 0.00 
cil10 cil6 0.53 86 0.00 0.50 157 0.00 0.67 122 0.00 
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csil2ra cil6 0.41 86 0.00 0.48 157 0.00 0.64 122 0.00 
cil12p40 cil6 0.50 86 0.00 0.36 157 0.00 0.47 122 0.00 
cil1ra cil6 0.06 86 0.65 0.05 157 0.55 0.03 122 0.78 
cil1b cil6 0.51 86 0.00 0.46 157 0.00 0.56 122 0.00 
cil1a cil6 0.39 86 0.00 0.30 157 0.00 0.41 122 0.00 
cil2 cil6 0.50 86 0.00 0.45 157 0.00 0.55 122 0.00 
cil4 cil17 0.75 31 0.00 0.51 72 0.00 0.60 51 0.00 
cil10 cil17 0.73 86 0.00 0.74 156 0.00 0.80 120 0.00 
csil2ra cil17 0.75 86 0.00 0.66 156 0.00 0.72 120 0.00 
cil12p40 cil17 0.73 86 0.00 0.73 156 0.00 0.78 120 0.00 
cil1ra cil17 0.05 86 0.66 0.07 156 0.42 0.11 120 0.26 
cil1b cil17 0.62 86 0.00 0.65 156 0.00 0.70 120 0.00 
cil1a cil17 0.45 86 0.00 0.49 156 0.00 0.57 120 0.00 
cil2 cil17 0.73 86 0.00 0.76 156 0.00 0.82 120 0.00 
cil6 cil17 0.40 86 0.00 0.42 156 0.00 0.60 120 0.00 
cil4 cil12p70 0.67 31 0.00 0.60 73 0.00 0.78 53 0.00 
cil10 cil12p70 0.52 31 0.00 0.63 73 0.00 0.66 53 0.00 
csil2ra cil12p70 0.73 31 0.00 0.37 73 0.00 0.57 53 0.00 
cil12p40 cil12p70 0.83 31 0.00 0.62 73 0.00 0.70 53 0.00 
cil1ra cil12p70 0.15 31 0.47 0.01 73 0.91 0.12 53 0.42 
cil1b cil12p70 0.66 31 0.00 0.57 73 0.00 0.72 53 0.00 
cil1a cil12p70 0.75 31 0.00 0.60 73 0.00 0.72 53 0.00 
cil2 cil12p70 0.60 31 0.00 0.47 73 0.00 0.67 53 0.00 
cil6 cil12p70 0.32 31 0.10 0.34 73 0.00 0.51 53 0.00 
cil17 cil12p70 0.78 31 0.00 0.56 72 0.00 0.70 51 0.00 
cil4 ctnfa 0.09 31 0.66 0.26 73 0.03 0.44 53 0.00 
cil10 ctnfa 0.60 86 0.00 0.36 157 0.00 0.54 122 0.00 
csil2ra ctnfa 0.43 86 0.00 0.48 157 0.00 0.53 122 0.00 
cil12p40 ctnfa 0.36 86 0.00 0.28 157 0.00 0.34 122 0.00 
cil1ra ctnfa 0.43 86 0.00 0.51 157 0.00 0.42 122 0.00 
cil1b ctnfa 0.24 86 0.04 0.02 157 0.84 0.07 122 0.44 
cil1a ctnfa 0.09 86 0.45 0.11 157 0.17 0.03 122 0.78 
cil2 ctnfa 0.47 86 0.00 0.31 157 0.00 0.42 122 0.00 
cil6 ctnfa 0.53 86 0.00 0.41 157 0.00 0.49 122 0.00 
cil17 ctnfa 0.45 86 0.00 0.29 156 0.00 0.41 120 0.00 
cil12p70 ctnfa 0.20 31 0.31 0.17 73 0.17 0.25 53 0.08 
cil4 cil8 0.34 31 0.08 0.27 73 0.03 0.32 53 0.02 
cil10 cil8 0.70 31 0.00 0.51 73 0.00 0.69 53 0.00 
csil2ra cil8 0.49 31 0.01 0.33 73 0.01 0.59 53 0.00 
cil12p40 cil8 0.44 31 0.02 0.31 73 0.01 0.52 53 0.00 
cil1ra cil8 0.13 31 0.53 0.11 73 0.38 0.22 53 0.13 
cil1b cil8 0.68 31 0.00 0.64 73 0.00 0.69 53 0.00 
cil1a cil8 0.46 31 0.01 0.36 73 0.00 0.64 53 0.00 
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cil2 cil8 0.41 31 0.03 0.55 73 0.00 0.65 53 0.00 
cil6 cil8 0.72 31 0.00 0.55 73 0.00 0.72 53 0.00 
cil17 cil8 0.55 31 0.00 0.53 72 0.00 0.70 51 0.00 
cil12p70 cil8 0.38 31 0.04 0.24 73 0.05 0.44 53 0.00 
ctnfa cil8 0.56 31 0.00 0.42 73 0.00 0.44 53 0.00 
cil4 ceotaxin 0.59 31 0.00 0.60 73 0.00 0.81 53 0.00 
cil10 ceotaxin 0.42 86 0.00 0.36 157 0.00 0.42 122 0.00 
csil2ra ceotaxin 0.67 86 0.00 0.55 157 0.00 0.55 122 0.00 
cil12p40 ceotaxin 0.61 86 0.00 0.58 157 0.00 0.59 122 0.00 
cil1ra ceotaxin 0.14 86 0.23 0.36 157 0.00 0.26 122 0.00 
cil1b ceotaxin 0.45 86 0.00 0.26 157 0.00 0.30 122 0.00 
cil1a ceotaxin 0.32 86 0.00 0.16 157 0.06 0.19 122 0.04 
cil2 ceotaxin 0.67 86 0.00 0.47 157 0.00 0.60 122 0.00 
cil6 ceotaxin 0.31 86 0.01 0.36 157 0.00 0.37 122 0.00 
cil17 ceotaxin 0.62 86 0.00 0.49 156 0.00 0.60 120 0.00 
cil12p70 ceotaxin 0.74 31 0.00 0.52 73 0.00 0.63 53 0.00 
ctnfa ceotaxin 0.46 86 0.00 0.50 157 0.00 0.56 122 0.00 
cil8 ceotaxin 0.24 31 0.24 0.04 73 0.77 0.24 53 0.10 
cil4 cmip1b 0.11 31 0.59 0.35 73 0.00 0.52 53 0.00 
cil10 cmip1b 0.48 86 0.00 0.38 157 0.00 0.53 122 0.00 
csil2ra cmip1b 0.45 86 0.00 0.57 157 0.00 0.60 122 0.00 
cil12p40 cmip1b 0.45 86 0.00 0.43 157 0.00 0.42 122 0.00 
cil1ra cmip1b 0.16 86 0.19 0.52 157 0.00 0.39 122 0.00 
cil1b cmip1b 0.44 86 0.00 0.17 157 0.05 0.22 122 0.02 
cil1a cmip1b 0.28 86 0.01 0.03 157 0.76 0.11 122 0.26 
cil2 cmip1b 0.45 86 0.00 0.38 157 0.00 0.49 122 0.00 
cil6 cmip1b 0.67 86 0.00 0.54 157 0.00 0.57 122 0.00 
cil17 cmip1b 0.33 86 0.00 0.36 156 0.00 0.41 120 0.00 
cil12p70 cmip1b 0.33 31 0.09 0.30 73 0.01 0.34 53 0.02 
ctnfa cmip1b 0.69 86 0.00 0.76 157 0.00 0.79 122 0.00 
cil8 cmip1b 0.61 31 0.00 0.47 73 0.00 0.54 53 0.00 
ceotaxin cmip1b 0.29 86 0.01 0.52 157 0.00 0.54 122 0.00 
cil4 cmcp1 0.03 31 0.88 0.22 73 0.07 0.50 53 0.00 
cil10 cmcp1 0.26 86 0.02 0.33 157 0.00 0.49 122 0.00 
csil2ra cmcp1 0.27 86 0.02 0.34 157 0.00 0.53 122 0.00 
cil12p40 cmcp1 0.15 86 0.20 0.20 157 0.02 0.31 122 0.00 
cil1ra cmcp1 0.11 86 0.33 0.34 157 0.00 0.28 122 0.00 
cil1b cmcp1 0.15 86 0.21 0.09 157 0.31 0.19 122 0.04 
cil1a cmcp1 0.02 86 0.88 0.07 157 0.40 0.09 122 0.37 
cil2 cmcp1 0.24 86 0.04 0.28 157 0.00 0.40 122 0.00 
cil6 cmcp1 0.58 86 0.00 0.46 157 0.00 0.60 122 0.00 
cil17 cmcp1 0.17 86 0.16 0.33 156 0.00 0.39 120 0.00 
cil12p70 cmcp1 0.06 31 0.78 0.24 73 0.05 0.37 53 0.01 
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ctnfa cmcp1 0.51 86 0.00 0.57 157 0.00 0.70 122 0.00 
cil8 cmcp1 0.70 31 0.00 0.55 73 0.00 0.56 53 0.00 
ceotaxin cmcp1 0.26 86 0.02 0.47 157 0.00 0.54 122 0.00 
cmip1b cmcp1 0.63 86 0.00 0.65 157 0.00 0.72 122 0.00 
cil4 cip10 0.59 31 0.00 0.46 73 0.00 0.64 53 0.00 
cil10 cip10 0.05 86 0.67 0.04 157 0.62 0.03 122 0.75 
csil2ra cip10 0.08 86 0.52 0.11 157 0.18 0.01 122 0.89 
cil12p40 cip10 0.13 86 0.27 0.12 157 0.15 0.08 122 0.40 
cil1ra cip10 0.17 86 0.14 0.05 157 0.57 0.07 122 0.47 
cil1b cip10 0.05 86 0.70 0.03 157 0.74 0.04 122 0.65 
cil1a cip10 0.17 86 0.16 0.14 157 0.10 0.22 122 0.02 
cil2 cip10 0.06 86 0.65 0.09 157 0.31 0.10 122 0.30 
cil6 cip10 0.27 86 0.02 0.26 157 0.00 0.15 122 0.11 
cil17 cip10 0.04 86 0.73 0.09 156 0.28 0.04 120 0.65 
cil12p70 cip10 0.61 31 0.00 0.55 73 0.00 0.59 53 0.00 
Ctnfa cip10 0.04 86 0.74 0.21 157 0.01 0.22 122 0.02 
cil8 cip10 0.42 31 0.03 0.20 73 0.11 0.38 53 0.01 
ceotaxin cip10 0.33 86 0.00 0.44 157 0.00 0.35 122 0.00 
cmip1b cip10 0.17 86 0.16 0.23 157 0.00 0.17 122 0.07 
cmcp1 cip10 0.35 86 0.00 0.41 157 0.00 0.33 122 0.00 
cil4 cinfg 0.54 31 0.00 0.49 73 0.00 0.75 53 0.00 
cil10 cinfg 0.56 31 0.00 0.47 73 0.00 0.62 53 0.00 
csil2ra cinfg 0.67 31 0.00 0.61 73 0.00 0.71 53 0.00 
cil12p40 cinfg 0.82 31 0.00 0.68 73 0.00 0.71 53 0.00 
cil1ra cinfg 0.05 31 0.78 0.19 73 0.11 0.03 53 0.84 
cil1b cinfg 0.67 31 0.00 0.40 73 0.00 0.70 53 0.00 
cil1a cinfg 0.60 31 0.00 0.42 73 0.00 0.65 53 0.00 
cil2 cinfg 0.79 31 0.00 0.51 73 0.00 0.72 53 0.00 
cil6 cinfg 0.55 31 0.00 0.56 73 0.00 0.71 53 0.00 
cil17 cinfg 0.61 31 0.00 0.32 72 0.01 0.72 51 0.00 
cil12p70 cinfg 0.76 31 0.00 0.45 73 0.00 0.64 53 0.00 
ctnfa cinfg 0.38 31 0.05 0.54 73 0.00 0.47 53 0.00 
cil8 cinfg 0.40 31 0.03 0.31 73 0.01 0.49 53 0.00 
ceotaxin cinfg 0.83 31 0.00 0.65 73 0.00 0.79 53 0.00 
cmip1b cinfg 0.54 31 0.00 0.62 73 0.00 0.57 53 0.00 
cmcp1 cinfg 0.25 31 0.21 0.49 73 0.00 0.60 53 0.00 
cip10 cinfg 0.64 31 0.00 0.57 73 0.00 0.54 53 0.00 
cil4 cmip1a 0.05 31 0.78 0.24 73 0.05 0.46 53 0.00 
cil10 cmip1a 0.41 86 0.00 0.29 157 0.00 0.46 122 0.00 
csil2ra cmip1a 0.31 86 0.01 0.46 157 0.00 0.50 122 0.00 
cil12p40 cmip1a 0.36 86 0.00 0.26 157 0.00 0.34 122 0.00 
cil1ra cmip1a 0.09 86 0.46 0.29 157 0.00 0.20 122 0.04 
cil1b cmip1a 0.38 86 0.00 0.18 157 0.03 0.27 122 0.00 
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cil1a cmip1a 0.29 86 0.01 0.12 157 0.15 0.21 122 0.03 
cil2 cmip1a 0.40 86 0.00 0.32 157 0.00 0.45 122 0.00 
cil6 cmip1a 0.73 86 0.00 0.58 157 0.00 0.60 122 0.00 
cil17 cmip1a 0.26 86 0.02 0.27 156 0.00 0.33 120 0.00 
cil12p70 cmip1a 0.25 31 0.21 0.25 73 0.04 0.26 53 0.07 
ctnfa cmip1a 0.55 86 0.00 0.61 157 0.00 0.66 122 0.00 
cil8 cmip1a 0.59 31 0.00 0.44 73 0.00 0.49 53 0.00 
ceotaxin cmip1a 0.20 86 0.08 0.26 157 0.00 0.34 122 0.00 
cmip1b cmip1a 0.83 86 0.00 0.79 157 0.00 0.78 122 0.00 
cmcp1 cmip1a 0.56 86 0.00 0.50 157 0.00 0.58 122 0.00 
cip10 cmip1a 0.13 86 0.28 0.21 157 0.01 0.22 122 0.02 
cinfg cmip1a 0.37 31 0.05 0.52 73 0.00 0.48 53 0.00 
cil4 cvegf 0.66 31 0.00 0.39 73 0.00 0.55 53 0.00 
cil10 cvegf 0.43 86 0.00 0.51 157 0.00 0.51 122 0.00 
csil2ra cvegf 0.56 86 0.00 0.43 157 0.00 0.39 122 0.00 
cil12p40 cvegf 0.63 86 0.00 0.52 157 0.00 0.58 122 0.00 
cil1ra cvegf 0.10 86 0.42 0.06 157 0.46 0.07 122 0.44 
cil1b cvegf 0.49 86 0.00 0.56 157 0.00 0.53 122 0.00 
cil1a cvegf 0.39 86 0.00 0.40 157 0.00 0.41 122 0.00 
cil2 cvegf 0.59 86 0.00 0.58 157 0.00 0.51 122 0.00 
cil6 cvegf 0.39 86 0.00 0.39 157 0.00 0.46 122 0.00 
cil17 cvegf 0.52 86 0.00 0.63 156 0.00 0.60 120 0.00 
cil12p70 cvegf 0.67 31 0.00 0.60 73 0.00 0.69 53 0.00 
ctnfa cvegf 0.21 86 0.07 0.10 157 0.22 0.14 122 0.13 
cil8 cvegf 0.52 31 0.00 0.50 73 0.00 0.68 53 0.00 
ceotaxin cvegf 0.50 86 0.00 0.42 157 0.00 0.42 122 0.00 
cmip1b cvegf 0.32 86 0.00 0.26 157 0.00 0.20 122 0.04 
cmcp1 cvegf 0.32 86 0.00 0.33 157 0.00 0.26 122 0.00 
cip10 cvegf 0.36 86 0.00 0.26 157 0.00 0.21 122 0.02 
cinfg cvegf 0.84 31 0.00 0.39 73 0.00 0.64 53 0.00 
cmip1a cvegf 0.19 86 0.09 0.14 157 0.10 0.14 122 0.15 
*False discovery rate based on Benjamini-Hochberg corrections for multiple testing 
c prefix indicates cervico-vaginal cytokine 






 118  
 
C. Figures S2.1. Cumulative distribution functions of cytokines (IL-1α, IL-1β, IL-1RA, and IL-2) 
evaluated among term births at three time points during pregnancy among 181 Mexico 
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D. Figures S2.2. Cumulative distribution functions of cytokines (IL-4, IL-6, IL-8, and IL-10) 
evaluated among term births at three time points during pregnancy among 181 Mexico 
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E. Figures S2.3. Cumulative distribution functions of cytokines (IL-12p40, IL-12p70, IL-17, and 
INF-γ) evaluated among term births at three time points during pregnancy among 181 
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F. Figures S2.4. Cumulative distribution functions of cytokines (IP-10, Eotaxin, MIP-1α, and 
MIP-1β) evaluated among term births at three time points during pregnancy among 181 
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G. Figures S2.5. Cumulative distribution functions of cytokines (MCP-1, sIL-2Rα, TNFα, and 
VEGF) evaluated among term births at three time points during pregnancy among 181 
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H. Table S4.1.  Table 4.3. Adjusted* odds ratios (OR) and 95% confidence intervals for preterm 
birth per log unit increase in cervico-vaginal cytokine concentration (pg/mL) from models† 
including one trimester alone (individual), all three trimesters entered (combined), and 
overall average (average), from a cohort in Mexico City, 2009-2014. 
 
 
Average Estimate OR (95% CI)
Cytokine N 1st 2nd 3rd 1st 2nd 3rd Average
Eotaxin 90 1.40 ( 1.05, 1.87) 1.30 ( 0.99, 1.71) 1.18 ( 0.88, 1.57) 1.68 ( 0.65, 4.34) 1.82 ( 0.51, 6.56) 0.44 ( 0.14, 1.37) 1.30 ( 0.97, 1.74)
IL-10 90 1.41 ( 1.07, 1.84) 1.34 ( 1.02, 1.74) 1.21 ( 0.91, 1.62) 1.35 ( 0.86, 2.14) 1.31 ( 0.67, 2.55) 0.77 ( 0.42, 1.40) 1.37 ( 1.03, 1.83)
IL-12p40 90 1.40 ( 1.06, 1.84) 1.35 ( 1.03, 1.76) 1.25 ( 0.96, 1.62) 1.32 ( 0.73, 2.39) 1.42 ( 0.58, 3.47) 0.75 ( 0.36, 1.53) 1.35 ( 1.02, 1.78)
IL-17 90 1.39 ( 1.04, 1.86) 1.30 ( 0.98, 1.74) 1.35 ( 0.99, 1.85) 1.34 ( 0.78, 2.31) 0.92 ( 0.47, 1.83) 1.15 ( 0.62, 2.14) 1.38 ( 1.01, 1.89)
IL-1α 90 0.79 ( 0.61, 1.02) 0.72 ( 0.54, 0.97) 0.72 ( 0.54, 0.95) 0.98 ( 0.64, 1.48) 0.92 ( 0.51, 1.64) 0.78 ( 0.47, 1.30) 0.69 ( 0.51, 0.94)
IL-1β 90 1.44 ( 1.07, 1.92) 1.35 ( 1.03, 1.76) 1.26 ( 0.99, 1.60) 1.34 ( 0.90, 2.00) 1.07 ( 0.68, 1.69) 1.03 ( 0.71, 1.48) 1.40 ( 1.05, 1.87)
IL-1RA 90 1.02 ( 0.79, 1.32) 1.10 ( 0.81, 1.49) 1.01 ( 0.79, 1.29) 0.87 ( 0.56, 1.34) 1.54 ( 0.73, 3.24) 0.80 ( 0.49, 1.32) 1.05 ( 0.78, 1.41)
IL-2 90 1.59 ( 1.14, 2.21) 1.55 ( 1.13, 2.13) 1.40 ( 1.01, 1.94) 1.35 ( 0.84, 2.17) 1.51 ( 0.78, 2.91) 0.81 ( 0.45, 1.46) 1.61 ( 1.14, 2.29)
IL-6 90 1.76 ( 1.28, 2.42) 1.32 ( 0.97, 1.78) 1.43 ( 1.11, 1.83) 1.74 ( 1.15, 2.63) 0.69 ( 0.34, 1.41) 1.31 ( 0.71, 2.41) 1.53 ( 1.13, 2.07)
IP-10 90 1.68 ( 1.19, 2.38) 1.62 ( 1.12, 2.34) 1.35 ( 0.96, 1.88) 1.50 ( 0.97, 2.33) 1.28 ( 0.64, 2.55) 0.94 ( 0.56, 1.56) 1.66 ( 1.13, 2.43)
MCP-1 90 1.62 ( 1.17, 2.24) 1.31 ( 0.94, 1.82) 1.26 ( 0.94, 1.70) 1.71 ( 1.15, 2.54) 0.82 ( 0.49, 1.36) 1.19 ( 0.82, 1.72) 1.45 ( 1.02, 2.06)
MIP-1α 90 1.63 ( 1.23, 2.16) 1.41 ( 1.09, 1.83) 1.27 ( 1.01, 1.61) 1.66 ( 1.13, 2.45) 1.20 ( 0.67, 2.15) 0.81 ( 0.49, 1.36) 1.47 ( 1.12, 1.92)
MIP-1β 90 1.43 ( 1.05, 1.96) 1.28 ( 0.96, 1.70) 1.20 ( 0.90, 1.60) 1.46 ( 0.93, 2.30) 1.16 ( 0.57, 2.34) 0.83 ( 0.43, 1.60) 1.32 ( 0.98, 1.78)
sIL-2Rα 90 1.39 ( 1.05, 1.85) 1.32 ( 0.97, 1.79) 1.22 ( 0.89, 1.66) 1.55 ( 0.84, 2.85) 1.27 ( 0.52, 3.15) 0.68 ( 0.31, 1.49) 1.34 ( 0.97, 1.84)
TNFα 90 1.34 ( 1.04, 1.73) 1.32 ( 1.01, 1.72) 1.28 ( 0.97, 1.68) 1.26 ( 0.86, 1.85) 1.06 ( 0.62, 1.81) 1.04 ( 0.66, 1.65) 1.38 ( 1.04, 1.84)
VEGF 90 2.11 ( 1.43, 3.10) 1.83 ( 1.29, 2.59) 1.49 ( 1.07, 2.09) 2.07 ( 1.16, 3.72) 1.38 ( 0.68, 2.82) 0.72 ( 0.40, 1.28) 1.95 ( 1.34, 2.84)
Blue font ≤ 0.1 after FDR adjustment for multiple testing
Table S4.1. Adjusted* odds ratios (OR) and 95% confidence intervals for preterm birth per log unit increase in cervico-vaginal cytokine concentration (pg/mL) from 
models† including one trimester alone (individual), all three trimesters entered (combined), and overall average (average), from a cohort  in Mexico City, 2009-14.
Individual Model Trimester Estimates OR (95% CI) Combined Model Estimates OR (95% CI)
*Models adjusted for age
† Cytokine measures up to eight months were included in the models
Green font p ≤ 0.05 after False Discovery Rate (FDR) adjustment for multiple testing
